Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cebpb
|
ENSMUSG00000056501.3 | CCAAT/enhancer binding protein (C/EBP), beta |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_167687679_167688497 | Cebpb | 827 | 0.416158 | 0.87 | 5.4e-18 | Click! |
chr2_167688815_167689311 | Cebpb | 148 | 0.858502 | 0.79 | 5.7e-13 | Click! |
chr2_167688545_167688770 | Cebpb | 258 | 0.806871 | 0.72 | 5.4e-10 | Click! |
chr2_167683824_167683981 | Cebpb | 5013 | 0.118035 | 0.67 | 2.5e-08 | Click! |
chr2_167680014_167680200 | Cebpb | 8808 | 0.105219 | 0.60 | 1.0e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 168.55 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr19_4059281_4059805 | 71.12 |
Gstp3 |
glutathione S-transferase pi 3 |
26 |
0.92 |
chr9_90303570_90303742 | 58.29 |
Gm30849 |
predicted gene, 30849 |
144 |
0.95 |
chr4_103386336_103386557 | 50.55 |
Gm12718 |
predicted gene 12718 |
3925 |
0.25 |
chr4_62516904_62517154 | 43.36 |
Alad |
aminolevulinate, delta-, dehydratase |
2852 |
0.16 |
chr16_23057965_23058373 | 43.03 |
Kng1 |
kininogen 1 |
81 |
0.92 |
chr12_15653337_15653804 | 42.57 |
Gm4804 |
predicted gene 4804 |
47158 |
0.15 |
chr9_69439815_69440027 | 41.92 |
Gm7802 |
predicted gene 7802 |
2674 |
0.17 |
chr6_146611446_146611715 | 41.86 |
Tm7sf3 |
transmembrane 7 superfamily member 3 |
22918 |
0.11 |
chr5_121216145_121216457 | 39.27 |
Hectd4 |
HECT domain E3 ubiquitin protein ligase 4 |
3918 |
0.16 |
chr12_71936600_71936835 | 39.17 |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
46987 |
0.14 |
chr8_89279855_89280239 | 38.74 |
Gm5356 |
predicted pseudogene 5356 |
92487 |
0.09 |
chr16_91522572_91522764 | 38.02 |
Mir6367 |
microRNA 6367 |
4876 |
0.11 |
chr5_100632845_100633119 | 37.69 |
Coq2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
31437 |
0.11 |
chr2_34828146_34828302 | 37.66 |
Fbxw2 |
F-box and WD-40 domain protein 2 |
1913 |
0.19 |
chr17_80786955_80787192 | 36.05 |
Map4k3 |
mitogen-activated protein kinase kinase kinase kinase 3 |
58588 |
0.12 |
chr9_107972304_107972473 | 36.04 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
3117 |
0.08 |
chr7_99167912_99168273 | 36.02 |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
2014 |
0.23 |
chr15_27477751_27477968 | 35.57 |
Tiaf2 |
TGF-beta1-induced anti-apoptotic factor 2 |
1147 |
0.44 |
chr5_89278221_89278372 | 35.21 |
Gc |
vitamin D binding protein |
157332 |
0.04 |
chr5_91961007_91961165 | 35.19 |
Thap6 |
THAP domain containing 6 |
1303 |
0.26 |
chr11_90259106_90259402 | 34.77 |
Mmd |
monocyte to macrophage differentiation-associated |
9778 |
0.22 |
chr8_36722399_36722687 | 34.57 |
Dlc1 |
deleted in liver cancer 1 |
10511 |
0.29 |
chr3_93469654_93469962 | 34.34 |
Tchhl1 |
trichohyalin-like 1 |
1054 |
0.33 |
chr5_97834809_97835101 | 34.21 |
Antxr2 |
anthrax toxin receptor 2 |
161140 |
0.03 |
chr19_55192593_55192828 | 33.76 |
Mir6715 |
microRNA 6715 |
32 |
0.93 |
chr10_94574788_94575101 | 33.59 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
313 |
0.87 |
chr13_96742964_96743239 | 33.57 |
Ankrd31 |
ankyrin repeat domain 31 |
5171 |
0.2 |
chr6_32167741_32168027 | 33.35 |
Gm13850 |
predicted gene 13850 |
55741 |
0.13 |
chr12_79557815_79558259 | 33.06 |
Rad51b |
RAD51 paralog B |
230684 |
0.02 |
chr15_25940377_25941010 | 32.97 |
Retreg1 |
reticulophagy regulator 1 |
9 |
0.98 |
chr10_93488540_93488698 | 32.44 |
Hal |
histidine ammonia lyase |
149 |
0.94 |
chr6_108836229_108836560 | 32.10 |
Edem1 |
ER degradation enhancer, mannosidase alpha-like 1 |
16 |
0.98 |
chr1_165769277_165769456 | 32.07 |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
110 |
0.93 |
chr11_35750522_35750899 | 31.96 |
Pank3 |
pantothenate kinase 3 |
18774 |
0.16 |
chr10_69300015_69300290 | 31.72 |
Gm40685 |
predicted gene, 40685 |
11987 |
0.17 |
chr8_114117604_114117774 | 31.71 |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
15868 |
0.27 |
chr11_80792214_80792464 | 31.65 |
Myo1d |
myosin ID |
12314 |
0.17 |
chr1_71938719_71938882 | 31.53 |
Gm28818 |
predicted gene 28818 |
21675 |
0.17 |
chr1_160079452_160079663 | 31.33 |
4930562F07Rik |
RIKEN cDNA 4930562F07 gene |
1572 |
0.34 |
chr14_73410214_73410365 | 31.32 |
Itm2b |
integral membrane protein 2B |
25000 |
0.17 |
chr6_117299934_117300226 | 31.12 |
Rpl28-ps4 |
ribosomal protein L28, pseudogene 4 |
86014 |
0.08 |
chr10_54042474_54042667 | 30.84 |
Gm47917 |
predicted gene, 47917 |
21241 |
0.18 |
chr1_60599018_60599192 | 30.66 |
Gm38388 |
predicted gene, 38388 |
2869 |
0.18 |
chr12_40891248_40891399 | 30.44 |
Gm19220 |
predicted gene, 19220 |
2162 |
0.26 |
chr8_69091131_69091302 | 30.42 |
Slc18a1 |
solute carrier family 18 (vesicular monoamine), member 1 |
1981 |
0.26 |
chr8_33855823_33856008 | 30.12 |
Rbpms |
RNA binding protein gene with multiple splicing |
2242 |
0.28 |
chr13_14033395_14033670 | 30.03 |
Tbce |
tubulin-specific chaperone E |
6047 |
0.13 |
chr10_42265424_42265606 | 30.01 |
Foxo3 |
forkhead box O3 |
7149 |
0.26 |
chr15_103258381_103258750 | 29.80 |
Nfe2 |
nuclear factor, erythroid derived 2 |
162 |
0.91 |
chr16_23029027_23029577 | 29.76 |
Kng2 |
kininogen 2 |
90 |
0.93 |
chr4_81673474_81673630 | 29.66 |
Gm11411 |
predicted gene 11411 |
22889 |
0.24 |
chr16_24199785_24200070 | 29.48 |
Gm31814 |
predicted gene, 31814 |
16319 |
0.19 |
chr15_11716579_11716737 | 29.42 |
Gm41271 |
predicted gene, 41271 |
12955 |
0.25 |
chr8_126807324_126807818 | 29.35 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
31662 |
0.17 |
chr4_58330975_58331128 | 29.24 |
Musk |
muscle, skeletal, receptor tyrosine kinase |
44876 |
0.17 |
chr8_67570409_67570727 | 29.16 |
Gm36247 |
predicted gene, 36247 |
14622 |
0.18 |
chr14_56620524_56620699 | 29.15 |
Gm16573 |
predicted gene 16573 |
98 |
0.96 |
chr15_100318235_100318415 | 29.07 |
Mettl7a1 |
methyltransferase like 7A1 |
13154 |
0.1 |
chr8_86766966_86767136 | 28.94 |
Siah1a |
siah E3 ubiquitin protein ligase 1A |
21117 |
0.16 |
chr14_76837658_76837828 | 28.90 |
Gm48968 |
predicted gene, 48968 |
4922 |
0.22 |
chr15_67048199_67048488 | 28.83 |
Gm31342 |
predicted gene, 31342 |
8285 |
0.23 |
chr9_54860727_54860881 | 28.77 |
Ireb2 |
iron responsive element binding protein 2 |
2985 |
0.23 |
chr12_79372810_79372961 | 28.54 |
Rad51b |
RAD51 paralog B |
45532 |
0.15 |
chr1_179561100_179561327 | 28.45 |
Cnst |
consortin, connexin sorting protein |
14704 |
0.15 |
chr3_38128678_38128843 | 28.31 |
Gm43821 |
predicted gene 43821 |
1431 |
0.43 |
chr4_49485579_49485762 | 28.18 |
Gm26424 |
predicted gene, 26424 |
11363 |
0.12 |
chr4_84431775_84431950 | 28.16 |
Gm12421 |
predicted gene 12421 |
2738 |
0.39 |
chr9_71165547_71165698 | 27.77 |
Aqp9 |
aquaporin 9 |
400 |
0.81 |
chr1_23163683_23163846 | 27.74 |
Ppp1r14bl |
protein phosphatase 1, regulatory inhibitor subunit 14B like |
61511 |
0.1 |
chr1_71912422_71912874 | 27.74 |
Gm28818 |
predicted gene 28818 |
4477 |
0.22 |
chr7_81688469_81688771 | 27.72 |
Homer2 |
homer scaffolding protein 2 |
4267 |
0.16 |
chr4_150853712_150854009 | 27.57 |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
59 |
0.94 |
chr4_123968744_123968901 | 27.55 |
Gm12902 |
predicted gene 12902 |
42588 |
0.1 |
chr6_90514496_90514652 | 27.53 |
Gm44236 |
predicted gene, 44236 |
1272 |
0.34 |
chr4_126017774_126017942 | 27.48 |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
6692 |
0.16 |
chr11_5380403_5380591 | 27.38 |
Znrf3 |
zinc and ring finger 3 |
1243 |
0.51 |
chr4_144960520_144960811 | 27.36 |
Gm38074 |
predicted gene, 38074 |
1817 |
0.36 |
chr11_21079867_21080065 | 27.22 |
Peli1 |
pellino 1 |
11325 |
0.2 |
chr7_65802902_65803113 | 27.15 |
1810008I18Rik |
RIKEN cDNA 1810008I18 gene |
104 |
0.97 |
chr6_149141174_149141634 | 27.07 |
Etfbkmt |
electron transfer flavoprotein beta subunit lysine methyltransferase |
109 |
0.95 |
chr3_104601780_104601945 | 27.06 |
Gm26091 |
predicted gene, 26091 |
623 |
0.61 |
chr18_56978164_56978384 | 27.01 |
C330018D20Rik |
RIKEN cDNA C330018D20 gene |
2906 |
0.3 |
chr7_66311315_66311537 | 27.01 |
Gm44752 |
predicted gene 44752 |
2231 |
0.27 |
chr11_83263267_83263444 | 26.96 |
Gm23444 |
predicted gene, 23444 |
8143 |
0.09 |
chr5_122145801_122145983 | 26.92 |
Ccdc63 |
coiled-coil domain containing 63 |
5069 |
0.14 |
chr3_51340298_51341882 | 26.82 |
Elf2 |
E74-like factor 2 |
427 |
0.74 |
chr1_191254488_191254811 | 26.73 |
Gm37074 |
predicted gene, 37074 |
5225 |
0.15 |
chr5_96949938_96950130 | 26.58 |
Gm43144 |
predicted gene 43144 |
9737 |
0.11 |
chr4_126173904_126174055 | 26.58 |
Thrap3 |
thyroid hormone receptor associated protein 3 |
452 |
0.71 |
chr17_40806499_40806942 | 26.57 |
Crisp2 |
cysteine-rich secretory protein 2 |
283 |
0.88 |
chr16_94347115_94347288 | 26.40 |
Gm15310 |
predicted gene 15310 |
12111 |
0.13 |
chr6_117653045_117653249 | 26.32 |
Gm45083 |
predicted gene 45083 |
40577 |
0.14 |
chr1_133685767_133686128 | 26.17 |
Lax1 |
lymphocyte transmembrane adaptor 1 |
4139 |
0.15 |
chr4_150003071_150003273 | 26.13 |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
42 |
0.97 |
chr1_60599372_60599567 | 26.09 |
Gm38388 |
predicted gene, 38388 |
3233 |
0.17 |
chr12_32944077_32944248 | 26.08 |
4933406C10Rik |
RIKEN cDNA 4933406C10 gene |
9621 |
0.12 |
chr2_60940262_60940686 | 25.99 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
22718 |
0.21 |
chr9_116091571_116091722 | 25.91 |
Gm9385 |
predicted pseudogene 9385 |
50582 |
0.13 |
chr4_40156199_40156488 | 25.88 |
Aco1 |
aconitase 1 |
7376 |
0.2 |
chr13_93672513_93672668 | 25.88 |
Bhmt2 |
betaine-homocysteine methyltransferase 2 |
1712 |
0.25 |
chr7_110848498_110848658 | 25.72 |
Rnf141 |
ring finger protein 141 |
4121 |
0.18 |
chr5_143058218_143058664 | 25.71 |
Gm43378 |
predicted gene 43378 |
8398 |
0.14 |
chr15_3251016_3251325 | 25.69 |
Selenop |
selenoprotein P |
17377 |
0.19 |
chr5_124021274_124021476 | 25.49 |
Vps37b |
vacuolar protein sorting 37B |
9662 |
0.1 |
chr14_68460162_68460313 | 25.46 |
Gm31227 |
predicted gene, 31227 |
1394 |
0.52 |
chr17_83659006_83659302 | 25.43 |
Kcng3 |
potassium voltage-gated channel, subfamily G, member 3 |
27259 |
0.19 |
chr1_184645673_184645857 | 25.41 |
Gm37800 |
predicted gene, 37800 |
16292 |
0.15 |
chr9_57300915_57301066 | 25.36 |
Gm18996 |
predicted gene, 18996 |
28425 |
0.12 |
chr16_23511404_23511561 | 25.35 |
Gm49514 |
predicted gene, 49514 |
2788 |
0.2 |
chr16_87612279_87612446 | 25.27 |
Gm22808 |
predicted gene, 22808 |
8758 |
0.19 |
chr13_43231981_43232458 | 25.22 |
Tbc1d7 |
TBC1 domain family, member 7 |
60718 |
0.11 |
chr9_21835276_21835808 | 25.10 |
Angptl8 |
angiopoietin-like 8 |
32 |
0.95 |
chr9_45040326_45040482 | 25.07 |
Mpzl2 |
myelin protein zero-like 2 |
227 |
0.84 |
chr4_145200002_145200404 | 25.04 |
Vps13d |
vacuolar protein sorting 13D |
5198 |
0.25 |
chr4_11102839_11103039 | 24.94 |
Gm11827 |
predicted gene 11827 |
19866 |
0.12 |
chr3_149170299_149170505 | 24.92 |
Gm42647 |
predicted gene 42647 |
39869 |
0.16 |
chr11_5502424_5502575 | 24.88 |
Gm11963 |
predicted gene 11963 |
3659 |
0.16 |
chr17_64609017_64609168 | 24.87 |
Man2a1 |
mannosidase 2, alpha 1 |
8356 |
0.26 |
chr13_56558914_56559089 | 24.80 |
Lect2 |
leukocyte cell-derived chemotaxin 2 |
10499 |
0.17 |
chr5_107749609_107749803 | 24.79 |
A430072P03Rik |
RIKEN cDNA A430072P03 gene |
23308 |
0.1 |
chr5_123202099_123202266 | 24.68 |
Gm43409 |
predicted gene 43409 |
10594 |
0.1 |
chr2_52602270_52602578 | 24.67 |
Bloc1s2-ps |
biogenesis of lysosomal organelles complex-1, subunit 2, pseudogene |
17330 |
0.2 |
chr2_152784673_152784911 | 24.60 |
Gm23802 |
predicted gene, 23802 |
11903 |
0.12 |
chr19_60795267_60795437 | 24.47 |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
4694 |
0.12 |
chr16_56801459_56801627 | 24.46 |
Adgrg7 |
adhesion G protein-coupled receptor G7 |
5688 |
0.19 |
chr1_137020655_137020828 | 24.44 |
Gm23763 |
predicted gene, 23763 |
30471 |
0.19 |
chr11_90240765_90240922 | 24.37 |
Mmd |
monocyte to macrophage differentiation-associated |
8613 |
0.21 |
chr3_127929993_127930179 | 24.36 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
13914 |
0.14 |
chr19_55131777_55131953 | 24.26 |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
4627 |
0.22 |
chr3_10247232_10247428 | 24.24 |
1700029B24Rik |
RIKEN cDNA 1700029B24 gene |
5518 |
0.11 |
chr7_109637333_109637620 | 24.24 |
Denn2b |
DENN domain containing 2B |
20329 |
0.14 |
chr3_142620269_142620452 | 24.23 |
Gbp2 |
guanylate binding protein 2 |
242 |
0.88 |
chr1_58101600_58101914 | 23.93 |
Aox3 |
aldehyde oxidase 3 |
11373 |
0.19 |
chr13_59771364_59771561 | 23.89 |
Etohd2 |
ethanol decreased 2 |
1496 |
0.18 |
chr4_118273791_118273962 | 23.85 |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
17398 |
0.16 |
chr15_82184680_82184902 | 23.82 |
Gm49502 |
predicted gene, 49502 |
725 |
0.46 |
chr11_86603943_86604094 | 23.80 |
Vmp1 |
vacuole membrane protein 1 |
1723 |
0.3 |
chr15_96802479_96802683 | 23.68 |
Gm8888 |
predicted gene 8888 |
35503 |
0.18 |
chr8_90892610_90892806 | 23.64 |
Gm45643 |
predicted gene 45643 |
447 |
0.76 |
chr9_57255200_57255351 | 23.58 |
1700017B05Rik |
RIKEN cDNA 1700017B05 gene |
6234 |
0.16 |
chr8_94186149_94186588 | 23.56 |
Gm39228 |
predicted gene, 39228 |
3079 |
0.13 |
chr7_26055182_26055442 | 23.55 |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
6185 |
0.14 |
chr16_37579969_37580291 | 23.53 |
Hgd |
homogentisate 1, 2-dioxygenase |
23 |
0.97 |
chr4_3373123_3373278 | 23.51 |
Gm11784 |
predicted gene 11784 |
13646 |
0.2 |
chr15_58755150_58755304 | 23.47 |
Gm20712 |
predicted gene 20712 |
26724 |
0.16 |
chr6_57513773_57513924 | 23.37 |
Ppm1k |
protein phosphatase 1K (PP2C domain containing) |
1759 |
0.29 |
chr11_109706146_109706312 | 23.23 |
Fam20a |
family with sequence similarity 20, member A |
16027 |
0.17 |
chr10_20046153_20046446 | 23.14 |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
53226 |
0.13 |
chr8_83423048_83423368 | 23.07 |
Scoc |
short coiled-coil protein |
14619 |
0.13 |
chr4_59440015_59440357 | 23.04 |
Susd1 |
sushi domain containing 1 |
1553 |
0.42 |
chr13_54629246_54629412 | 22.99 |
Faf2 |
Fas associated factor family member 2 |
7491 |
0.12 |
chr16_90738037_90738648 | 22.97 |
Mrap |
melanocortin 2 receptor accessory protein |
18 |
0.97 |
chr3_88442986_88443141 | 22.97 |
Sema4a |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
1924 |
0.14 |
chr15_100436248_100436399 | 22.85 |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
11251 |
0.1 |
chr8_47652810_47652961 | 22.78 |
Gm8623 |
predicted gene 8623 |
20121 |
0.1 |
chr6_100063117_100063316 | 22.75 |
Gm33201 |
predicted gene, 33201 |
72001 |
0.09 |
chr1_152273506_152273790 | 22.72 |
Gm38238 |
predicted gene, 38238 |
18880 |
0.24 |
chr19_41835767_41836202 | 22.71 |
Frat1 |
frequently rearranged in advanced T cell lymphomas |
6014 |
0.15 |
chr14_105370182_105370333 | 22.70 |
5430440P10Rik |
RIKEN cDNA 5430440P10 gene |
57302 |
0.1 |
chr10_99232602_99232787 | 22.67 |
Gm34777 |
predicted gene, 34777 |
423 |
0.72 |
chr4_35097022_35097220 | 22.62 |
Ifnk |
interferon kappa |
54935 |
0.11 |
chr16_21825593_21825853 | 22.58 |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
219 |
0.89 |
chr12_98375326_98375477 | 22.57 |
5330409N07Rik |
RIKEN cDNA 5330409N07 gene |
72933 |
0.08 |
chr17_85090414_85090730 | 22.53 |
Camkmt |
calmodulin-lysine N-methyltransferase |
20 |
0.84 |
chr5_66079454_66079619 | 22.50 |
Rbm47 |
RNA binding motif protein 47 |
1448 |
0.29 |
chr6_17568755_17568934 | 22.46 |
Met |
met proto-oncogene |
21871 |
0.2 |
chr13_52822783_52823147 | 22.46 |
BB123696 |
expressed sequence BB123696 |
65760 |
0.12 |
chr15_91178761_91178912 | 22.42 |
Abcd2 |
ATP-binding cassette, sub-family D (ALD), member 2 |
6651 |
0.21 |
chrX_12323329_12323480 | 22.41 |
Gm14635 |
predicted gene 14635 |
21818 |
0.25 |
chr8_34478557_34478729 | 22.38 |
Gm45349 |
predicted gene 45349 |
5648 |
0.19 |
chr18_54846546_54846732 | 22.38 |
Gm50365 |
predicted gene, 50365 |
8594 |
0.18 |
chr2_156850557_156850851 | 22.21 |
Tgif2 |
TGFB-induced factor homeobox 2 |
132 |
0.87 |
chr6_108457545_108458223 | 22.14 |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
819 |
0.61 |
chr1_82184268_82184419 | 22.11 |
Gm9747 |
predicted gene 9747 |
48769 |
0.13 |
chr10_87051926_87052102 | 21.94 |
1700113H08Rik |
RIKEN cDNA 1700113H08 gene |
6031 |
0.21 |
chr5_125273680_125274112 | 21.92 |
Gm32585 |
predicted gene, 32585 |
1081 |
0.48 |
chr1_137751556_137751944 | 21.91 |
Gm37099 |
predicted gene, 37099 |
15777 |
0.17 |
chr15_76697423_76698657 | 21.88 |
Gpt |
glutamic pyruvic transaminase, soluble |
22 |
0.93 |
chr9_67842830_67842995 | 21.79 |
Vps13c |
vacuolar protein sorting 13C |
2500 |
0.28 |
chr15_27451938_27452106 | 21.78 |
Gm36899 |
predicted gene, 36899 |
11427 |
0.16 |
chr5_92524852_92525027 | 21.73 |
Scarb2 |
scavenger receptor class B, member 2 |
18106 |
0.15 |
chr11_99063825_99063976 | 21.72 |
Tns4 |
tensin 4 |
9964 |
0.13 |
chr6_119137853_119138062 | 21.68 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
29384 |
0.19 |
chrX_74424134_74424310 | 21.67 |
Ikbkg |
inhibitor of kappaB kinase gamma |
312 |
0.79 |
chr12_103989150_103989341 | 21.66 |
Serpina11 |
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 |
672 |
0.54 |
chr11_102168828_102168979 | 21.61 |
Tmem101 |
transmembrane protein 101 |
12499 |
0.08 |
chr8_80493820_80494107 | 21.58 |
Gypa |
glycophorin A |
182 |
0.96 |
chr11_95012361_95012546 | 21.55 |
Samd14 |
sterile alpha motif domain containing 14 |
2172 |
0.18 |
chr11_79771332_79771811 | 21.53 |
9130204K15Rik |
RIKEN cDNA 9130204K15 gene |
11316 |
0.16 |
chr15_100320593_100320744 | 21.52 |
Mettl7a3 |
methyltransferase like 7A3 |
14261 |
0.1 |
chr9_64953225_64953560 | 21.43 |
Slc24a1 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 |
1785 |
0.27 |
chr5_90689778_90690109 | 21.43 |
Rassf6 |
Ras association (RalGDS/AF-6) domain family member 6 |
49286 |
0.09 |
chr5_123181667_123181829 | 21.36 |
Hpd |
4-hydroxyphenylpyruvic acid dioxygenase |
319 |
0.78 |
chr2_103516612_103516763 | 21.36 |
Gm13996 |
predicted gene 13996 |
30572 |
0.14 |
chr16_34825281_34825432 | 21.32 |
Mylk |
myosin, light polypeptide kinase |
40435 |
0.18 |
chr11_4697787_4697975 | 21.27 |
Uqcr10 |
ubiquinol-cytochrome c reductase, complex III subunit X |
6172 |
0.16 |
chr8_126849924_126850228 | 21.25 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
10843 |
0.2 |
chr18_3839754_3840089 | 21.23 |
Rpl7a-ps6 |
ribosomal protein L7A, pseudogene 6 |
18659 |
0.24 |
chr11_117083539_117083733 | 21.23 |
Gm24323 |
predicted gene, 24323 |
2200 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.7 | 13.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
12.2 | 60.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
11.3 | 56.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
10.7 | 32.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
10.6 | 31.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
10.1 | 30.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
9.4 | 28.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
9.4 | 28.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
9.1 | 45.5 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
8.9 | 26.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
8.6 | 34.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
8.4 | 42.1 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
8.3 | 24.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
8.1 | 24.2 | GO:0008050 | female courtship behavior(GO:0008050) |
8.0 | 72.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
8.0 | 24.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
7.8 | 23.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
7.6 | 38.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
7.5 | 22.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
7.4 | 37.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
7.4 | 22.2 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
7.0 | 28.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
7.0 | 7.0 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
7.0 | 27.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
6.9 | 34.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
6.8 | 27.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
6.8 | 20.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
6.5 | 6.5 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
6.5 | 25.9 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
6.3 | 31.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
6.2 | 18.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
6.2 | 37.2 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
6.0 | 24.0 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
5.9 | 17.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
5.9 | 5.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
5.8 | 35.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
5.8 | 5.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
5.8 | 5.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
5.8 | 23.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
5.7 | 22.8 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
5.6 | 16.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
5.6 | 16.8 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
5.6 | 5.6 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
5.5 | 16.6 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
5.5 | 22.0 | GO:0003383 | apical constriction(GO:0003383) |
5.4 | 27.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
5.4 | 16.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
5.4 | 32.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
5.4 | 21.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
5.4 | 16.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
5.4 | 27.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
5.4 | 21.5 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
5.4 | 48.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
5.4 | 10.7 | GO:0072718 | response to cisplatin(GO:0072718) |
5.3 | 15.9 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
5.3 | 15.9 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
5.3 | 21.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
5.1 | 20.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
5.1 | 5.1 | GO:1904707 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
5.1 | 20.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
5.1 | 15.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
5.1 | 10.1 | GO:0051665 | membrane raft localization(GO:0051665) |
5.1 | 15.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
5.0 | 10.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
4.8 | 4.8 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
4.8 | 4.8 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
4.8 | 4.8 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
4.8 | 4.8 | GO:0006573 | valine metabolic process(GO:0006573) |
4.7 | 9.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
4.7 | 33.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
4.7 | 28.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
4.7 | 14.0 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
4.7 | 14.0 | GO:0036394 | amylase secretion(GO:0036394) |
4.7 | 27.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
4.6 | 9.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
4.5 | 22.6 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
4.5 | 13.5 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
4.4 | 13.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
4.4 | 13.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
4.4 | 21.9 | GO:0009115 | xanthine catabolic process(GO:0009115) |
4.4 | 4.4 | GO:0070627 | ferrous iron import(GO:0070627) |
4.3 | 13.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
4.3 | 12.9 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
4.3 | 25.7 | GO:0015871 | choline transport(GO:0015871) |
4.3 | 17.2 | GO:0050904 | diapedesis(GO:0050904) |
4.2 | 4.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
4.2 | 12.7 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
4.2 | 16.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
4.2 | 25.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
4.1 | 12.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
4.1 | 12.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
4.1 | 4.1 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
4.0 | 12.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
4.0 | 12.0 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
4.0 | 7.9 | GO:0002432 | granuloma formation(GO:0002432) |
3.9 | 15.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
3.9 | 11.7 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
3.9 | 3.9 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
3.9 | 19.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
3.8 | 7.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
3.8 | 15.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
3.8 | 11.4 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
3.8 | 11.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
3.8 | 7.6 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
3.8 | 3.8 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
3.8 | 11.4 | GO:0007525 | somatic muscle development(GO:0007525) |
3.8 | 15.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
3.7 | 26.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
3.7 | 14.9 | GO:0048625 | myoblast fate commitment(GO:0048625) |
3.7 | 14.8 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
3.7 | 25.8 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
3.7 | 25.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
3.7 | 22.1 | GO:0000050 | urea cycle(GO:0000050) |
3.7 | 7.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
3.6 | 10.9 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
3.6 | 7.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
3.6 | 7.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
3.6 | 10.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
3.6 | 43.2 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
3.6 | 7.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
3.6 | 10.7 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
3.6 | 14.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
3.5 | 14.2 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
3.5 | 24.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
3.5 | 7.0 | GO:0032348 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
3.5 | 10.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
3.5 | 10.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.5 | 17.5 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
3.5 | 10.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
3.5 | 10.5 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
3.5 | 17.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
3.5 | 10.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
3.5 | 17.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
3.4 | 3.4 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
3.4 | 6.9 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
3.4 | 10.3 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
3.4 | 10.1 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
3.4 | 10.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
3.4 | 3.4 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
3.3 | 23.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
3.3 | 3.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
3.3 | 16.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
3.3 | 16.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
3.3 | 13.1 | GO:0015808 | L-alanine transport(GO:0015808) |
3.3 | 22.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
3.3 | 9.8 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
3.2 | 3.2 | GO:0042117 | monocyte activation(GO:0042117) |
3.2 | 25.9 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
3.2 | 9.7 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
3.2 | 12.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
3.2 | 12.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
3.2 | 6.4 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
3.2 | 19.0 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
3.1 | 6.3 | GO:0015817 | histidine transport(GO:0015817) |
3.1 | 6.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
3.1 | 9.4 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
3.1 | 6.2 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
3.1 | 105.9 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
3.1 | 6.2 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
3.1 | 9.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
3.1 | 9.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
3.1 | 12.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
3.0 | 9.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
3.0 | 9.1 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
3.0 | 42.3 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
3.0 | 9.0 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
3.0 | 8.9 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
3.0 | 8.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
3.0 | 5.9 | GO:0032898 | neurotrophin production(GO:0032898) |
3.0 | 5.9 | GO:0045472 | response to ether(GO:0045472) |
2.9 | 8.8 | GO:0032264 | IMP salvage(GO:0032264) |
2.9 | 11.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
2.9 | 14.7 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
2.9 | 8.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
2.9 | 20.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.9 | 2.9 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
2.9 | 43.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
2.9 | 17.4 | GO:0090166 | Golgi disassembly(GO:0090166) |
2.9 | 2.9 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
2.9 | 2.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
2.9 | 5.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
2.9 | 14.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
2.8 | 11.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.8 | 2.8 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
2.8 | 5.7 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
2.8 | 11.3 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
2.8 | 8.5 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
2.8 | 5.6 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
2.8 | 16.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
2.8 | 5.6 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
2.8 | 5.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
2.8 | 8.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
2.8 | 8.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
2.8 | 8.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.7 | 24.5 | GO:0006555 | methionine metabolic process(GO:0006555) |
2.7 | 8.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.7 | 8.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.7 | 2.7 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.7 | 10.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.7 | 8.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
2.7 | 13.5 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
2.7 | 5.4 | GO:0060435 | bronchiole development(GO:0060435) |
2.7 | 8.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
2.7 | 5.3 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
2.7 | 5.3 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
2.6 | 7.9 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
2.6 | 15.8 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
2.6 | 7.9 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
2.6 | 2.6 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
2.6 | 28.8 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
2.6 | 2.6 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
2.6 | 18.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
2.6 | 2.6 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
2.6 | 12.9 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
2.6 | 10.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.6 | 5.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.6 | 28.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
2.6 | 20.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
2.6 | 7.7 | GO:0032621 | interleukin-18 production(GO:0032621) |
2.6 | 5.1 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
2.5 | 7.6 | GO:0019086 | late viral transcription(GO:0019086) |
2.5 | 10.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.5 | 10.1 | GO:0009597 | detection of virus(GO:0009597) |
2.5 | 5.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
2.5 | 7.5 | GO:0043622 | cortical microtubule organization(GO:0043622) |
2.5 | 14.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
2.5 | 4.9 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
2.5 | 24.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
2.5 | 37.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
2.5 | 7.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
2.5 | 9.8 | GO:1902969 | mitotic DNA replication(GO:1902969) |
2.5 | 9.8 | GO:1905206 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
2.5 | 9.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
2.5 | 9.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
2.5 | 9.8 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
2.4 | 9.7 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
2.4 | 19.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
2.4 | 7.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
2.4 | 16.9 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
2.4 | 19.3 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
2.4 | 7.2 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.4 | 2.4 | GO:0035973 | aggrephagy(GO:0035973) |
2.4 | 2.4 | GO:0032673 | regulation of interleukin-4 production(GO:0032673) |
2.4 | 2.4 | GO:0017085 | response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
2.4 | 9.5 | GO:0070836 | caveola assembly(GO:0070836) |
2.4 | 9.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
2.4 | 4.7 | GO:0006817 | phosphate ion transport(GO:0006817) |
2.4 | 7.1 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
2.4 | 9.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.3 | 2.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
2.3 | 9.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
2.3 | 21.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
2.3 | 4.7 | GO:0030033 | microvillus assembly(GO:0030033) |
2.3 | 72.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
2.3 | 9.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
2.3 | 14.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
2.3 | 23.3 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
2.3 | 14.0 | GO:0033572 | transferrin transport(GO:0033572) |
2.3 | 9.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
2.3 | 7.0 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
2.3 | 2.3 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
2.3 | 2.3 | GO:0007619 | courtship behavior(GO:0007619) |
2.3 | 27.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
2.3 | 9.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
2.3 | 2.3 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
2.3 | 22.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
2.3 | 4.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
2.3 | 2.3 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
2.3 | 2.3 | GO:0031498 | chromatin disassembly(GO:0031498) |
2.3 | 2.3 | GO:0033058 | directional locomotion(GO:0033058) |
2.3 | 9.1 | GO:0015825 | L-serine transport(GO:0015825) |
2.3 | 6.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
2.3 | 9.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
2.3 | 47.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
2.3 | 6.8 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
2.3 | 9.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
2.3 | 11.3 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
2.2 | 11.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
2.2 | 6.7 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
2.2 | 8.9 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
2.2 | 8.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
2.2 | 11.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
2.2 | 2.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
2.2 | 2.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
2.2 | 13.3 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
2.2 | 17.7 | GO:0030575 | nuclear body organization(GO:0030575) |
2.2 | 28.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
2.2 | 6.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.2 | 4.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
2.2 | 19.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
2.2 | 6.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
2.2 | 4.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
2.2 | 2.2 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
2.2 | 15.3 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
2.2 | 6.5 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
2.2 | 4.3 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
2.2 | 2.2 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
2.2 | 6.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.2 | 2.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
2.2 | 17.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
2.1 | 17.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
2.1 | 12.9 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
2.1 | 6.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
2.1 | 6.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
2.1 | 25.5 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
2.1 | 12.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
2.1 | 12.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
2.1 | 8.4 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
2.1 | 4.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
2.1 | 8.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.1 | 6.3 | GO:0070295 | renal water absorption(GO:0070295) |
2.1 | 2.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
2.1 | 4.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
2.1 | 6.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
2.1 | 14.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
2.1 | 4.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.1 | 8.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
2.1 | 8.3 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
2.1 | 12.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
2.1 | 6.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
2.1 | 8.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
2.1 | 14.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
2.1 | 6.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
2.1 | 10.3 | GO:0016264 | gap junction assembly(GO:0016264) |
2.1 | 14.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
2.0 | 8.2 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
2.0 | 10.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
2.0 | 10.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
2.0 | 2.0 | GO:0006525 | arginine metabolic process(GO:0006525) |
2.0 | 6.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
2.0 | 4.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.0 | 8.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
2.0 | 20.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
2.0 | 18.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
2.0 | 31.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
2.0 | 4.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
2.0 | 5.9 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
2.0 | 4.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.0 | 2.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
2.0 | 3.9 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
2.0 | 11.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
2.0 | 13.8 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
2.0 | 3.9 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
2.0 | 3.9 | GO:0060037 | pharyngeal system development(GO:0060037) |
2.0 | 19.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
2.0 | 7.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
2.0 | 3.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.0 | 5.9 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.9 | 9.7 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.9 | 9.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.9 | 3.9 | GO:0007144 | female meiosis I(GO:0007144) |
1.9 | 3.9 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
1.9 | 1.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.9 | 3.9 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.9 | 5.8 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.9 | 7.8 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.9 | 21.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.9 | 7.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.9 | 3.8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.9 | 7.6 | GO:0048368 | lateral mesoderm development(GO:0048368) |
1.9 | 1.9 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
1.9 | 1.9 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
1.9 | 3.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.9 | 18.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.9 | 15.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
1.9 | 11.3 | GO:0045979 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
1.9 | 3.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.9 | 5.6 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.9 | 13.1 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
1.9 | 7.5 | GO:0051031 | tRNA transport(GO:0051031) |
1.9 | 9.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.9 | 11.2 | GO:0006477 | protein sulfation(GO:0006477) |
1.9 | 3.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.9 | 24.2 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
1.9 | 9.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.9 | 7.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.9 | 13.0 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
1.9 | 5.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.9 | 11.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.9 | 1.9 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
1.8 | 9.2 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.8 | 7.4 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.8 | 3.7 | GO:0002215 | defense response to nematode(GO:0002215) |
1.8 | 16.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
1.8 | 44.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
1.8 | 7.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
1.8 | 11.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.8 | 1.8 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
1.8 | 3.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.8 | 5.5 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.8 | 12.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
1.8 | 3.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.8 | 3.6 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.8 | 5.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.8 | 7.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.8 | 7.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.8 | 10.8 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
1.8 | 3.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.8 | 3.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
1.8 | 16.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
1.8 | 1.8 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
1.8 | 28.5 | GO:0034340 | response to type I interferon(GO:0034340) |
1.8 | 12.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
1.8 | 5.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
1.8 | 7.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.8 | 17.8 | GO:0042026 | protein refolding(GO:0042026) |
1.8 | 1.8 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
1.8 | 3.5 | GO:0052803 | histamine metabolic process(GO:0001692) imidazole-containing compound metabolic process(GO:0052803) |
1.8 | 10.6 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.8 | 5.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.8 | 5.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.8 | 1.8 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.8 | 1.8 | GO:1901563 | response to camptothecin(GO:1901563) |
1.7 | 59.4 | GO:0006956 | complement activation(GO:0006956) |
1.7 | 8.7 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
1.7 | 3.5 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.7 | 7.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.7 | 3.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.7 | 12.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.7 | 1.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.7 | 8.7 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
1.7 | 1.7 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.7 | 6.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.7 | 1.7 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.7 | 6.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.7 | 10.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.7 | 3.4 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
1.7 | 36.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
1.7 | 8.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
1.7 | 1.7 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
1.7 | 23.7 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
1.7 | 11.8 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
1.7 | 25.4 | GO:0002021 | response to dietary excess(GO:0002021) |
1.7 | 3.4 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
1.7 | 3.4 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
1.7 | 5.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.7 | 10.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.7 | 6.7 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
1.7 | 5.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
1.7 | 5.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
1.7 | 3.3 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.7 | 6.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
1.7 | 3.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.7 | 41.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
1.7 | 5.0 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
1.6 | 6.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.6 | 1.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.6 | 4.9 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.6 | 3.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.6 | 16.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.6 | 3.3 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
1.6 | 6.5 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
1.6 | 1.6 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
1.6 | 4.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.6 | 13.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.6 | 4.8 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
1.6 | 11.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.6 | 4.8 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
1.6 | 12.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.6 | 3.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.6 | 6.3 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
1.6 | 4.7 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
1.6 | 12.6 | GO:0043248 | proteasome assembly(GO:0043248) |
1.6 | 4.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
1.6 | 11.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.6 | 1.6 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
1.6 | 3.1 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
1.6 | 4.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.6 | 18.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
1.6 | 20.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.6 | 4.7 | GO:0030242 | pexophagy(GO:0030242) |
1.6 | 4.7 | GO:0015888 | thiamine transport(GO:0015888) |
1.6 | 9.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.6 | 7.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.6 | 7.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.6 | 18.7 | GO:1901741 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
1.6 | 1.6 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
1.5 | 12.3 | GO:0007097 | nuclear migration(GO:0007097) |
1.5 | 1.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.5 | 3.1 | GO:1902075 | cellular response to salt(GO:1902075) |
1.5 | 30.4 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
1.5 | 9.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.5 | 9.1 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
1.5 | 1.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.5 | 4.5 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
1.5 | 9.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
1.5 | 1.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.5 | 1.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.5 | 13.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
1.5 | 13.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.5 | 4.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.5 | 1.5 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.5 | 17.9 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
1.5 | 29.6 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
1.5 | 10.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.5 | 7.4 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.5 | 5.9 | GO:0002576 | platelet degranulation(GO:0002576) |
1.5 | 1.5 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
1.5 | 1.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.5 | 1.5 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
1.5 | 4.4 | GO:0070842 | aggresome assembly(GO:0070842) |
1.5 | 5.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
1.5 | 4.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.5 | 2.9 | GO:0031269 | pseudopodium assembly(GO:0031269) |
1.5 | 2.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.5 | 7.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.5 | 1.5 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
1.5 | 1.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.5 | 4.4 | GO:0001302 | replicative cell aging(GO:0001302) |
1.4 | 5.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.4 | 1.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
1.4 | 10.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.4 | 11.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.4 | 18.8 | GO:0046174 | polyol catabolic process(GO:0046174) |
1.4 | 7.2 | GO:0097459 | iron ion import into cell(GO:0097459) |
1.4 | 2.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.4 | 4.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.4 | 17.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.4 | 18.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.4 | 1.4 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.4 | 2.9 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.4 | 2.9 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
1.4 | 2.8 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
1.4 | 4.3 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.4 | 9.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.4 | 4.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
1.4 | 5.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.4 | 1.4 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
1.4 | 22.5 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
1.4 | 9.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.4 | 5.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.4 | 5.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
1.4 | 4.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
1.4 | 1.4 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.4 | 19.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
1.4 | 5.6 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
1.4 | 7.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.4 | 5.6 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
1.4 | 2.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.4 | 1.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.4 | 18.1 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
1.4 | 5.6 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
1.4 | 4.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
1.4 | 1.4 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
1.4 | 5.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
1.4 | 4.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.4 | 8.3 | GO:0032060 | bleb assembly(GO:0032060) |
1.4 | 4.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
1.4 | 1.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.4 | 1.4 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
1.4 | 1.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.4 | 5.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.4 | 1.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.4 | 2.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.4 | 4.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.4 | 4.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
1.4 | 5.5 | GO:0060613 | fat pad development(GO:0060613) |
1.4 | 9.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.4 | 4.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.4 | 9.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.4 | 17.7 | GO:0006465 | signal peptide processing(GO:0006465) |
1.4 | 4.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
1.4 | 2.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.4 | 1.4 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
1.4 | 1.4 | GO:0009838 | abscission(GO:0009838) |
1.4 | 9.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.4 | 1.4 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
1.4 | 37.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
1.3 | 16.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
1.3 | 1.3 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
1.3 | 6.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.3 | 4.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
1.3 | 4.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.3 | 8.0 | GO:0051639 | actin filament network formation(GO:0051639) |
1.3 | 2.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.3 | 8.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.3 | 2.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.3 | 10.6 | GO:0046688 | response to copper ion(GO:0046688) |
1.3 | 1.3 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.3 | 11.9 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.3 | 5.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.3 | 7.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.3 | 2.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.3 | 73.4 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
1.3 | 1.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.3 | 19.5 | GO:0007141 | male meiosis I(GO:0007141) |
1.3 | 1.3 | GO:0032252 | secretory granule localization(GO:0032252) |
1.3 | 1.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
1.3 | 14.3 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
1.3 | 2.6 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
1.3 | 1.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.3 | 23.4 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
1.3 | 2.6 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
1.3 | 1.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.3 | 1.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.3 | 2.6 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.3 | 3.9 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.3 | 1.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.3 | 2.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
1.3 | 1.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
1.3 | 3.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.3 | 6.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
1.3 | 8.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.3 | 1.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.3 | 3.8 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
1.3 | 2.5 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
1.3 | 1.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.3 | 2.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.3 | 3.8 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
1.3 | 5.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.3 | 2.5 | GO:0010039 | response to iron ion(GO:0010039) |
1.3 | 5.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.3 | 10.0 | GO:0050892 | intestinal absorption(GO:0050892) |
1.3 | 3.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.2 | 1.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.2 | 2.5 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
1.2 | 1.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.2 | 3.7 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.2 | 1.2 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
1.2 | 2.5 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
1.2 | 2.5 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.2 | 46.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
1.2 | 7.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
1.2 | 4.9 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
1.2 | 1.2 | GO:0015747 | urate transport(GO:0015747) |
1.2 | 2.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.2 | 1.2 | GO:0061438 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
1.2 | 3.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.2 | 3.7 | GO:0015744 | succinate transport(GO:0015744) |
1.2 | 9.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.2 | 4.9 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
1.2 | 1.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.2 | 6.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.2 | 6.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.2 | 7.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.2 | 3.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.2 | 4.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.2 | 4.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
1.2 | 2.4 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
1.2 | 1.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.2 | 2.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.2 | 4.8 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
1.2 | 7.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
1.2 | 5.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.2 | 3.6 | GO:0032439 | endosome localization(GO:0032439) |
1.2 | 1.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.2 | 2.4 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.2 | 2.4 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.2 | 4.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.2 | 8.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
1.2 | 14.2 | GO:0051601 | exocyst localization(GO:0051601) |
1.2 | 8.3 | GO:0010388 | cullin deneddylation(GO:0010388) |
1.2 | 4.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.2 | 1.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
1.2 | 2.4 | GO:0070922 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) small RNA loading onto RISC(GO:0070922) |
1.2 | 1.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
1.2 | 19.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.2 | 7.0 | GO:0046415 | urate metabolic process(GO:0046415) |
1.2 | 9.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
1.2 | 2.3 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
1.2 | 4.6 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.2 | 2.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
1.2 | 1.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
1.2 | 1.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.2 | 3.5 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.2 | 23.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
1.2 | 3.5 | GO:2000209 | regulation of anoikis(GO:2000209) |
1.2 | 3.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.1 | 1.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.1 | 2.3 | GO:0044550 | melanin metabolic process(GO:0006582) secondary metabolite biosynthetic process(GO:0044550) |
1.1 | 2.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.1 | 3.4 | GO:0034310 | ethanol catabolic process(GO:0006068) primary alcohol catabolic process(GO:0034310) |
1.1 | 1.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.1 | 4.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.1 | 1.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.1 | 1.1 | GO:0045078 | interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
1.1 | 4.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
1.1 | 3.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.1 | 10.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
1.1 | 1.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
1.1 | 1.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.1 | 3.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.1 | 9.0 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
1.1 | 1.1 | GO:0070254 | mucus secretion(GO:0070254) |
1.1 | 1.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.1 | 5.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.1 | 3.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.1 | 6.7 | GO:0019321 | pentose metabolic process(GO:0019321) |
1.1 | 1.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.1 | 7.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
1.1 | 4.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.1 | 7.8 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.1 | 3.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.1 | 2.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
1.1 | 1.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
1.1 | 3.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
1.1 | 3.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.1 | 5.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.1 | 3.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
1.1 | 2.2 | GO:0036166 | phenotypic switching(GO:0036166) |
1.1 | 7.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
1.1 | 6.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.1 | 23.1 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
1.1 | 10.9 | GO:0016572 | histone phosphorylation(GO:0016572) |
1.1 | 7.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.1 | 2.2 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
1.1 | 3.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
1.1 | 15.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
1.1 | 2.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.1 | 9.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
1.1 | 2.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.1 | 6.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.1 | 2.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.1 | 16.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
1.1 | 5.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.1 | 16.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
1.1 | 2.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
1.1 | 7.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.1 | 2.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
1.1 | 3.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
1.1 | 5.4 | GO:0060539 | diaphragm development(GO:0060539) |
1.1 | 4.3 | GO:0048535 | lymph node development(GO:0048535) |
1.1 | 2.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.1 | 33.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
1.1 | 2.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
1.1 | 14.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
1.1 | 5.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.1 | 2.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
1.1 | 4.3 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
1.1 | 30.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
1.1 | 14.9 | GO:0048538 | thymus development(GO:0048538) |
1.1 | 3.2 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
1.1 | 3.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
1.1 | 1.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
1.1 | 19.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
1.1 | 1.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.1 | 2.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
1.1 | 3.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.1 | 3.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.1 | 4.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.1 | 3.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.1 | 3.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.0 | 5.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.0 | 3.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.0 | 6.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.0 | 3.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.0 | 3.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
1.0 | 2.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
1.0 | 17.6 | GO:0006301 | postreplication repair(GO:0006301) |
1.0 | 1.0 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.0 | 3.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.0 | 1.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
1.0 | 22.7 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
1.0 | 1.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.0 | 3.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
1.0 | 3.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
1.0 | 2.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) COPII-coated vesicle budding(GO:0090114) |
1.0 | 2.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
1.0 | 1.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.0 | 5.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
1.0 | 1.0 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.0 | 2.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.0 | 6.1 | GO:0008209 | androgen metabolic process(GO:0008209) |
1.0 | 3.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.0 | 5.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.0 | 7.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
1.0 | 4.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
1.0 | 2.0 | GO:0019042 | viral latency(GO:0019042) |
1.0 | 2.0 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
1.0 | 5.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
1.0 | 1.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.0 | 2.0 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
1.0 | 1.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.0 | 4.0 | GO:0051026 | chiasma assembly(GO:0051026) |
1.0 | 9.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.0 | 12.0 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
1.0 | 6.0 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
1.0 | 2.0 | GO:0042737 | drug catabolic process(GO:0042737) |
1.0 | 10.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
1.0 | 6.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.0 | 3.0 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.0 | 2.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.0 | 5.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.0 | 1.0 | GO:2000152 | negative regulation of protein deubiquitination(GO:0090086) regulation of ubiquitin-specific protease activity(GO:2000152) |
1.0 | 40.6 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
1.0 | 2.0 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
1.0 | 16.8 | GO:0019835 | cytolysis(GO:0019835) |
1.0 | 4.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.0 | 13.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
1.0 | 9.8 | GO:0014850 | response to muscle activity(GO:0014850) |
1.0 | 2.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.0 | 1.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
1.0 | 2.9 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
1.0 | 30.4 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
1.0 | 2.9 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.0 | 1.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.0 | 2.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.0 | 1.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.0 | 1.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.0 | 1.9 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
1.0 | 3.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.0 | 2.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.0 | 1.9 | GO:0061074 | regulation of neural retina development(GO:0061074) |
1.0 | 1.9 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
1.0 | 1.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.0 | 3.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.0 | 5.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.0 | 2.9 | GO:0046836 | glycolipid transport(GO:0046836) |
1.0 | 1.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
1.0 | 7.7 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
1.0 | 1.0 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
1.0 | 1.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.0 | 2.9 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.0 | 17.2 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
1.0 | 11.4 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.9 | 4.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.9 | 2.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.9 | 0.9 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.9 | 0.9 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.9 | 3.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.9 | 5.6 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.9 | 0.9 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.9 | 9.4 | GO:0006828 | manganese ion transport(GO:0006828) |
0.9 | 1.9 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.9 | 6.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.9 | 6.6 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.9 | 0.9 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.9 | 2.8 | GO:0048254 | snoRNA localization(GO:0048254) |
0.9 | 3.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.9 | 5.6 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.9 | 5.6 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.9 | 0.9 | GO:0060544 | regulation of necroptotic process(GO:0060544) |
0.9 | 7.4 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.9 | 1.9 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.9 | 36.1 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.9 | 2.8 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.9 | 2.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.9 | 0.9 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.9 | 1.8 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.9 | 1.8 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.9 | 6.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.9 | 5.5 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.9 | 0.9 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.9 | 4.6 | GO:0018101 | protein citrullination(GO:0018101) |
0.9 | 1.8 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.9 | 2.7 | GO:0010226 | response to lithium ion(GO:0010226) |
0.9 | 6.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.9 | 10.9 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.9 | 0.9 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.9 | 8.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.9 | 0.9 | GO:0051610 | serotonin uptake(GO:0051610) |
0.9 | 1.8 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.9 | 3.6 | GO:0001774 | microglial cell activation(GO:0001774) |
0.9 | 3.6 | GO:0001842 | neural fold formation(GO:0001842) |
0.9 | 0.9 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.9 | 1.8 | GO:0044351 | macropinocytosis(GO:0044351) |
0.9 | 3.6 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.9 | 3.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.9 | 6.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.9 | 2.7 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.9 | 1.8 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.9 | 2.6 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.9 | 5.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.9 | 0.9 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.9 | 6.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.9 | 2.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.9 | 1.8 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.9 | 2.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.9 | 1.8 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.9 | 1.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.9 | 0.9 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.9 | 4.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.9 | 2.6 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.9 | 3.5 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.9 | 2.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.9 | 1.7 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.9 | 0.9 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.9 | 3.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.9 | 3.5 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.9 | 1.7 | GO:0048102 | autophagic cell death(GO:0048102) |
0.9 | 5.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.9 | 12.0 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.9 | 1.7 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.9 | 1.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.9 | 1.7 | GO:0050779 | RNA destabilization(GO:0050779) |
0.9 | 0.9 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.9 | 2.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.9 | 6.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.9 | 0.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.9 | 2.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.9 | 0.9 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.8 | 0.8 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.8 | 1.7 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.8 | 1.7 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.8 | 3.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.8 | 2.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.8 | 16.9 | GO:0030261 | chromosome condensation(GO:0030261) |
0.8 | 6.7 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.8 | 1.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.8 | 2.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.8 | 0.8 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.8 | 4.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.8 | 1.7 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.8 | 4.2 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.8 | 0.8 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) |
0.8 | 3.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.8 | 3.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.8 | 1.7 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.8 | 0.8 | GO:0035425 | autocrine signaling(GO:0035425) |
0.8 | 6.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.8 | 2.5 | GO:0015819 | lysine transport(GO:0015819) |
0.8 | 1.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.8 | 3.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.8 | 1.6 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.8 | 0.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.8 | 26.3 | GO:0007566 | embryo implantation(GO:0007566) |
0.8 | 3.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.8 | 2.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.8 | 1.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.8 | 1.6 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.8 | 2.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.8 | 6.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.8 | 3.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.8 | 21.2 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.8 | 5.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.8 | 3.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.8 | 4.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.8 | 3.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.8 | 1.6 | GO:0006903 | vesicle targeting(GO:0006903) |
0.8 | 4.0 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.8 | 1.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.8 | 0.8 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.8 | 1.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.8 | 11.2 | GO:0019915 | lipid storage(GO:0019915) |
0.8 | 0.8 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.8 | 5.6 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.8 | 1.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.8 | 2.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.8 | 1.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.8 | 0.8 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.8 | 0.8 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.8 | 7.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.8 | 4.7 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.8 | 1.6 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.8 | 1.6 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.8 | 2.3 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.8 | 2.3 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.8 | 2.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.8 | 4.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.8 | 8.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.8 | 3.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.8 | 0.8 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.8 | 3.9 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.8 | 10.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.8 | 6.1 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.8 | 4.6 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.8 | 1.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.8 | 27.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.8 | 1.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.8 | 0.8 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.8 | 3.0 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.8 | 5.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.8 | 5.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.8 | 0.8 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.8 | 8.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.8 | 3.0 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.8 | 2.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.8 | 3.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.8 | 0.8 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.7 | 2.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.7 | 3.0 | GO:0090151 | protein import into mitochondrial inner membrane(GO:0045039) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.7 | 9.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.7 | 7.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.7 | 2.2 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.7 | 1.5 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.7 | 1.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.7 | 1.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.7 | 0.7 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.7 | 0.7 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.7 | 1.5 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.7 | 0.7 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.7 | 0.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.7 | 0.7 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.7 | 5.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.7 | 6.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.7 | 2.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.7 | 1.5 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.7 | 0.7 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.7 | 8.7 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.7 | 1.4 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.7 | 0.7 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.7 | 0.7 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.7 | 2.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.7 | 2.2 | GO:0042772 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.7 | 3.6 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.7 | 12.2 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.7 | 1.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.7 | 1.4 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.7 | 29.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.7 | 4.3 | GO:0032869 | cellular response to insulin stimulus(GO:0032869) |
0.7 | 2.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.7 | 1.4 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.7 | 0.7 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.7 | 0.7 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.7 | 4.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.7 | 0.7 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.7 | 1.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.7 | 1.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.7 | 3.5 | GO:0072678 | T cell migration(GO:0072678) |
0.7 | 3.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.7 | 16.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.7 | 5.6 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.7 | 2.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.7 | 30.8 | GO:0050817 | coagulation(GO:0050817) |
0.7 | 3.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.7 | 0.7 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.7 | 0.7 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.7 | 18.1 | GO:0007569 | cell aging(GO:0007569) |
0.7 | 0.7 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.7 | 4.9 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.7 | 2.8 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.7 | 0.7 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.7 | 5.5 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.7 | 1.4 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.7 | 3.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.7 | 0.7 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.7 | 0.7 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.7 | 0.7 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.7 | 2.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.7 | 0.7 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.7 | 1.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.7 | 3.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.7 | 0.7 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.7 | 6.7 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.7 | 0.7 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.7 | 1.3 | GO:0051231 | spindle elongation(GO:0051231) |
0.7 | 0.7 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.7 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.7 | 0.7 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.7 | 0.7 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.7 | 1.3 | GO:0097205 | renal filtration(GO:0097205) |
0.7 | 4.7 | GO:0009205 | purine ribonucleoside triphosphate metabolic process(GO:0009205) |
0.7 | 2.0 | GO:0045580 | regulation of T cell differentiation(GO:0045580) |
0.7 | 1.3 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.7 | 1.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.7 | 0.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.7 | 10.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.7 | 3.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.7 | 1.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.7 | 1.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.7 | 2.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.7 | 2.0 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.7 | 23.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.7 | 4.6 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.7 | 0.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.7 | 0.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.7 | 19.0 | GO:0009408 | response to heat(GO:0009408) |
0.7 | 2.0 | GO:0097186 | amelogenesis(GO:0097186) |
0.7 | 2.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.6 | 0.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.6 | 3.9 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.6 | 7.1 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.6 | 3.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.6 | 1.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.6 | 0.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 0.6 | GO:0010165 | response to X-ray(GO:0010165) |
0.6 | 1.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.6 | 7.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 1.3 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.6 | 2.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.6 | 2.6 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.6 | 1.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.6 | 3.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.6 | 9.5 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.6 | 10.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.6 | 4.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.6 | 5.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.6 | 1.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.6 | 0.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.6 | 0.6 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.6 | 10.1 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.6 | 3.1 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.6 | 1.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.6 | 6.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.6 | 2.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 8.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.6 | 4.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.6 | 1.9 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.6 | 2.5 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.6 | 1.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.6 | 0.6 | GO:0009624 | response to nematode(GO:0009624) |
0.6 | 2.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.6 | 7.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.6 | 0.6 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.6 | 4.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.6 | 1.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.6 | 1.8 | GO:0032098 | regulation of appetite(GO:0032098) |
0.6 | 1.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.6 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.6 | 14.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.6 | 3.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.6 | 1.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.6 | 3.0 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.6 | 9.7 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.6 | 3.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.6 | 1.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.6 | 2.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.6 | 6.6 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.6 | 1.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.6 | 3.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.6 | 1.8 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.6 | 2.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.6 | 1.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.6 | 1.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.6 | 1.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.6 | 4.8 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.6 | 3.0 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.6 | 13.0 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.6 | 0.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.6 | 11.2 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.6 | 4.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.6 | 0.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.6 | 1.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.6 | 1.8 | GO:0044827 | positive regulation by host of viral process(GO:0044794) modulation by host of viral genome replication(GO:0044827) |
0.6 | 0.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.6 | 4.7 | GO:0043489 | RNA stabilization(GO:0043489) |
0.6 | 1.8 | GO:0032309 | icosanoid secretion(GO:0032309) |
0.6 | 0.6 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.6 | 1.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.6 | 1.7 | GO:2000833 | positive regulation of steroid hormone secretion(GO:2000833) |
0.6 | 1.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.6 | 0.6 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.6 | 1.2 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.6 | 0.6 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.6 | 0.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.6 | 0.6 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.6 | 10.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.6 | 13.8 | GO:0070167 | regulation of biomineral tissue development(GO:0070167) |
0.6 | 1.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.6 | 0.6 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 12.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.6 | 0.6 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.6 | 2.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.6 | 32.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.6 | 1.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.6 | 0.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.6 | 1.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.6 | 2.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.6 | 1.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.6 | 15.2 | GO:1901998 | toxin transport(GO:1901998) |
0.6 | 1.7 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.6 | 2.8 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.6 | 7.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.6 | 3.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.6 | 1.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.6 | 3.9 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.6 | 2.8 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.6 | 2.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.6 | 34.4 | GO:0051028 | mRNA transport(GO:0051028) |
0.6 | 0.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.6 | 3.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.6 | 0.6 | GO:0018158 | protein oxidation(GO:0018158) |
0.6 | 0.6 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.5 | 10.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.5 | 2.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.5 | 18.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.5 | 0.5 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.5 | 0.5 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.5 | 6.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.5 | 3.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.5 | 1.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.5 | 1.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.5 | 0.5 | GO:0098930 | axonal transport(GO:0098930) |
0.5 | 3.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.5 | 5.4 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.5 | 3.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.5 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.5 | 0.5 | GO:2000826 | regulation of heart morphogenesis(GO:2000826) |
0.5 | 1.1 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.5 | 1.1 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.5 | 2.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.5 | 1.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.5 | 0.5 | GO:0060416 | response to growth hormone(GO:0060416) |
0.5 | 1.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.5 | 6.3 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.5 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 0.5 | GO:0006862 | nucleotide transport(GO:0006862) |
0.5 | 5.2 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.5 | 2.1 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.5 | 1.0 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine transport(GO:0015870) acetylcholine secretion(GO:0061526) acetate ester transport(GO:1901374) |
0.5 | 1.6 | GO:0009629 | response to gravity(GO:0009629) |
0.5 | 15.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.5 | 6.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.5 | 0.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.5 | 1.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 0.5 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.5 | 0.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.5 | 1.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.5 | 0.5 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.5 | 5.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.5 | 4.6 | GO:0098868 | bone growth(GO:0098868) |
0.5 | 8.2 | GO:0009268 | response to pH(GO:0009268) |
0.5 | 0.5 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.5 | 0.5 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.5 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 0.5 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.5 | 2.0 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.5 | 2.0 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.5 | 2.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.5 | 1.5 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.5 | 9.6 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.5 | 2.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.5 | 3.0 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.5 | 1.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.5 | 1.0 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.5 | 0.5 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.5 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.5 | 1.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.5 | 1.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.5 | 1.0 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.5 | 0.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.5 | 4.0 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.5 | 1.5 | GO:0050931 | pigment cell differentiation(GO:0050931) |
0.5 | 1.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 2.9 | GO:0036065 | fucosylation(GO:0036065) |
0.5 | 2.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 0.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.5 | 1.5 | GO:0007343 | egg activation(GO:0007343) |
0.5 | 3.9 | GO:0032608 | interferon-beta production(GO:0032608) |
0.5 | 1.0 | GO:0044838 | cell quiescence(GO:0044838) |
0.5 | 0.5 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.5 | 1.0 | GO:0043276 | anoikis(GO:0043276) |
0.5 | 1.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.5 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.5 | 3.8 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.5 | 1.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.5 | 1.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 1.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.5 | 7.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.5 | 1.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.5 | 0.9 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.5 | 9.9 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.5 | 4.7 | GO:0034505 | tooth mineralization(GO:0034505) |
0.5 | 5.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.5 | 0.5 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.5 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.5 | 0.9 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.5 | 0.5 | GO:0010042 | response to manganese ion(GO:0010042) |
0.5 | 1.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.5 | 13.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.5 | 6.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.5 | 0.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.5 | 0.9 | GO:0070266 | necroptotic process(GO:0070266) |
0.5 | 0.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.5 | 2.3 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 1.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.5 | 0.9 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.5 | 3.7 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.5 | 1.4 | GO:0033622 | integrin activation(GO:0033622) |
0.5 | 0.5 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.5 | 0.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.5 | 1.8 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.5 | 0.9 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.5 | 1.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.5 | 2.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 0.9 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.5 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.4 | 4.0 | GO:0007584 | response to nutrient(GO:0007584) |
0.4 | 0.4 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.4 | 1.8 | GO:0071514 | genetic imprinting(GO:0071514) |
0.4 | 0.9 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.4 | 1.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 2.7 | GO:0031639 | plasminogen activation(GO:0031639) |
0.4 | 0.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.4 | 1.8 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.4 | 0.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.4 | 0.4 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 1.3 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.4 | 0.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.4 | 1.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.4 | 4.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.4 | 5.3 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.4 | 9.2 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.4 | 0.9 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.4 | 2.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.4 | 0.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.4 | 0.9 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 2.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.4 | 1.7 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.4 | 0.4 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.4 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 0.4 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.4 | 3.4 | GO:0007614 | short-term memory(GO:0007614) |
0.4 | 41.1 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.4 | 0.9 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 0.4 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.4 | 1.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.4 | 1.7 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.4 | 0.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.4 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 1.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 0.4 | GO:0051767 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.4 | 1.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 0.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.4 | 3.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.4 | 2.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.4 | 0.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.4 | 1.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.4 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 0.8 | GO:0070417 | cellular response to cold(GO:0070417) |
0.4 | 0.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 2.0 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.4 | 0.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 15.8 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.4 | 0.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 19.5 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.4 | 0.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 1.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.4 | 2.8 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.4 | 0.4 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) |
0.4 | 1.2 | GO:0007032 | endosome organization(GO:0007032) |
0.4 | 1.6 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.4 | 0.4 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.4 | 1.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 7.6 | GO:0009201 | ribonucleoside triphosphate biosynthetic process(GO:0009201) |
0.4 | 0.8 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.4 | 0.8 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.4 | 14.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.4 | 3.6 | GO:0035904 | aorta development(GO:0035904) |
0.4 | 1.2 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.4 | 0.4 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.4 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.4 | 0.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.4 | 0.4 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.4 | 0.4 | GO:0018904 | ether metabolic process(GO:0018904) |
0.4 | 0.4 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.4 | 1.6 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.4 | 1.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.4 | 1.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.4 | 6.1 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.4 | 0.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 1.1 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.4 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 0.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 1.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 0.4 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.4 | 1.5 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) pyridine-containing compound catabolic process(GO:0072526) |
0.4 | 3.0 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.4 | 6.7 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.4 | 2.2 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.4 | 1.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.4 | 1.1 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.4 | 0.4 | GO:0002864 | regulation of acute inflammatory response to antigenic stimulus(GO:0002864) |
0.4 | 1.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.4 | 0.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 1.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.4 | 8.4 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.4 | 8.0 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.4 | 2.9 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.4 | 0.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 2.9 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.4 | 5.3 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.4 | 0.4 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.4 | 3.9 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 0.4 | GO:0033574 | response to testosterone(GO:0033574) |
0.4 | 0.4 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.4 | 0.4 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.4 | 3.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.4 | 1.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.4 | 18.6 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.3 | 1.0 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.3 | 4.2 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.3 | 1.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 2.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.3 | 1.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.7 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.3 | 1.0 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.3 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 1.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 0.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 1.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 1.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 0.7 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.3 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.3 | 2.0 | GO:0046677 | response to antibiotic(GO:0046677) |
0.3 | 0.3 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.3 | 0.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 0.7 | GO:0031058 | positive regulation of histone modification(GO:0031058) |
0.3 | 1.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.3 | 0.7 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 1.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 1.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.3 | 1.3 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.3 | 17.2 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.3 | 5.5 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.3 | 2.3 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.3 | 1.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 0.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.3 | 0.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 1.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.3 | 0.3 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.3 | 0.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 1.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 0.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 0.3 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.3 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 0.3 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.3 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 0.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 3.4 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 0.3 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.3 | 1.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.3 | 6.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 1.2 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.3 | 3.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 1.8 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.3 | 3.6 | GO:0042255 | ribosome assembly(GO:0042255) |
0.3 | 0.3 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.3 | 0.3 | GO:0009301 | snRNA transcription(GO:0009301) |
0.3 | 0.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 0.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.3 | 0.9 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 0.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 0.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 2.4 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.3 | 0.6 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.3 | 2.1 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.3 | 0.6 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 0.9 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.3 | 2.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 1.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.3 | 0.6 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
0.3 | 1.2 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.3 | 20.5 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.3 | 1.4 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 0.3 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.3 | 1.7 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 0.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 2.3 | GO:0070633 | transepithelial transport(GO:0070633) |
0.3 | 0.3 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.3 | 0.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 0.3 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.3 | 3.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.3 | 0.8 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
0.3 | 0.5 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.3 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 0.5 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 1.6 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.3 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.3 | 0.5 | GO:0043543 | protein acylation(GO:0043543) |
0.3 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.3 | 3.2 | GO:0051168 | nuclear export(GO:0051168) |
0.3 | 1.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 1.3 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 0.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 1.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 0.3 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) |
0.3 | 1.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.3 | 1.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 0.3 | GO:0032768 | regulation of monooxygenase activity(GO:0032768) |
0.3 | 0.8 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.3 | 1.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 0.5 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.3 | 0.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.3 | 1.0 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.3 | 3.6 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.3 | 0.3 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.3 | 0.8 | GO:0032418 | lysosome localization(GO:0032418) |
0.3 | 0.3 | GO:0051799 | negative regulation of epidermis development(GO:0045683) negative regulation of hair follicle development(GO:0051799) |
0.3 | 2.0 | GO:0016575 | histone deacetylation(GO:0016575) |
0.3 | 0.3 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.3 | 0.5 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.3 | 4.0 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.3 | 0.3 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.3 | 0.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 0.2 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.2 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 1.0 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 16.3 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.2 | 0.5 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.2 | 0.2 | GO:0070206 | protein trimerization(GO:0070206) |
0.2 | 3.4 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.2 | 0.7 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 1.0 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 1.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 1.7 | GO:0018394 | peptidyl-lysine acetylation(GO:0018394) |
0.2 | 0.7 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.2 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 0.2 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.2 | 0.5 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 1.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.2 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 4.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 0.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 0.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.5 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.2 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 12.7 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.2 | 1.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.5 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.2 | 0.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.2 | 3.9 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.2 | 0.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 3.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.2 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.2 | 0.2 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.2 | 0.9 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.2 | 2.7 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.2 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 4.0 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 0.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.4 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.2 | 1.1 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.2 | 0.2 | GO:0002719 | negative regulation of cytokine production involved in immune response(GO:0002719) |
0.2 | 2.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 1.3 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.2 | 0.2 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.2 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.2 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 0.2 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.2 | 0.4 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.2 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 1.5 | GO:0051923 | sulfation(GO:0051923) |
0.2 | 2.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 1.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.2 | 4.1 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 1.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 0.6 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.2 | 0.2 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.2 | 3.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.2 | 0.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.4 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.2 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.2 | 0.4 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.2 | 0.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 1.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 0.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.4 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 0.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 0.2 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 4.9 | GO:0035264 | multicellular organism growth(GO:0035264) |
0.2 | 1.5 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.2 | 1.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 1.3 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 0.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 0.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.2 | GO:0034121 | regulation of toll-like receptor signaling pathway(GO:0034121) |
0.2 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.4 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 0.4 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.2 | 0.2 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.2 | 1.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 0.2 | GO:0046164 | alcohol catabolic process(GO:0046164) |
0.2 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 2.8 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.2 | 0.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 2.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 2.6 | GO:0031929 | TOR signaling(GO:0031929) |
0.2 | 0.7 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.2 | 0.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.5 | GO:0046632 | alpha-beta T cell differentiation(GO:0046632) |
0.2 | 0.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 2.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.2 | GO:0035283 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.5 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.2 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 4.5 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.2 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 1.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.2 | 8.0 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.2 | 1.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.3 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.2 | 0.2 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.2 | 0.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 1.5 | GO:0001824 | blastocyst development(GO:0001824) |
0.2 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 3.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.7 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.1 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 0.1 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.3 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 1.6 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.3 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 1.0 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 37.6 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.1 | 0.7 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 27.7 | GO:0007283 | spermatogenesis(GO:0007283) |
0.1 | 1.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.1 | GO:0050942 | regulation of developmental pigmentation(GO:0048070) positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.3 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.1 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of reactive oxygen species biosynthetic process(GO:1903427) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.1 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.1 | 0.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.1 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.1 | GO:1904714 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 7.1 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 18.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.1 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.1 | 0.5 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 0.2 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 1.8 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
0.1 | 0.6 | GO:0009154 | purine ribonucleotide catabolic process(GO:0009154) |
0.1 | 0.2 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 0.5 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.1 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.1 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.3 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.1 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 2.7 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.1 | GO:0048232 | male gamete generation(GO:0048232) |
0.1 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 5.6 | GO:0010876 | lipid localization(GO:0010876) |
0.1 | 0.1 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.3 | GO:0060840 | artery development(GO:0060840) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.5 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 3.6 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.2 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
0.1 | 0.3 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 3.6 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.1 | 0.5 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 1.9 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.4 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 1.0 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.4 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.1 | GO:0090075 | relaxation of muscle(GO:0090075) |
0.1 | 4.5 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.4 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
0.1 | 6.4 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 1.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.2 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 0.4 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 1.3 | GO:0019439 | aromatic compound catabolic process(GO:0019439) |
0.1 | 0.2 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.1 | 3.2 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.4 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 7.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.1 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.1 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.1 | 0.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 2.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.4 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.1 | GO:0009144 | purine nucleoside triphosphate metabolic process(GO:0009144) |
0.1 | 0.1 | GO:0046700 | heterocycle catabolic process(GO:0046700) |
0.1 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.1 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.1 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.1 | 0.1 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.2 | GO:0070197 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.0 | GO:0097529 | myeloid leukocyte migration(GO:0097529) |
0.0 | 0.0 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.0 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.0 | 0.0 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.0 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.0 | 0.1 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.0 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.0 | GO:0019068 | virion assembly(GO:0019068) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.0 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.0 | GO:0072179 | nephric duct formation(GO:0072179) |
0.0 | 1.3 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 38.1 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 1.7 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:1901888 | regulation of cell junction assembly(GO:1901888) |
0.0 | 0.0 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.0 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.0 | 0.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.0 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.0 | GO:0001821 | histamine secretion(GO:0001821) |
0.0 | 0.1 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.0 | GO:0071321 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.1 | 24.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
7.7 | 7.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
7.5 | 37.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
6.3 | 38.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
6.3 | 6.3 | GO:0000811 | GINS complex(GO:0000811) |
5.8 | 17.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
5.7 | 28.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
5.5 | 21.9 | GO:0033269 | internode region of axon(GO:0033269) |
5.4 | 16.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
5.3 | 16.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
4.7 | 42.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
4.6 | 22.8 | GO:0045180 | basal cortex(GO:0045180) |
4.3 | 21.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
3.9 | 15.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
3.9 | 19.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
3.9 | 11.6 | GO:0097513 | myosin II filament(GO:0097513) |
3.8 | 41.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
3.7 | 14.6 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
3.6 | 14.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
3.6 | 14.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
3.4 | 13.5 | GO:0071953 | elastic fiber(GO:0071953) |
3.3 | 40.0 | GO:0042627 | chylomicron(GO:0042627) |
3.2 | 9.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
3.2 | 9.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
3.1 | 12.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
3.1 | 6.2 | GO:0005579 | membrane attack complex(GO:0005579) |
3.1 | 12.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.0 | 3.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
3.0 | 15.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
3.0 | 9.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.9 | 8.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
2.9 | 75.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
2.9 | 17.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
2.8 | 14.2 | GO:0031252 | cell leading edge(GO:0031252) |
2.8 | 8.4 | GO:0097452 | GAIT complex(GO:0097452) |
2.8 | 11.0 | GO:0045298 | tubulin complex(GO:0045298) |
2.7 | 8.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.6 | 7.9 | GO:1990357 | terminal web(GO:1990357) |
2.6 | 13.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
2.6 | 15.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.6 | 7.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
2.6 | 12.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
2.5 | 10.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.5 | 17.7 | GO:0043203 | axon hillock(GO:0043203) |
2.5 | 10.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
2.5 | 7.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
2.5 | 7.5 | GO:0097443 | sorting endosome(GO:0097443) |
2.5 | 17.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
2.5 | 239.6 | GO:0072562 | blood microparticle(GO:0072562) |
2.5 | 27.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
2.4 | 7.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.4 | 7.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
2.4 | 2.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
2.4 | 9.5 | GO:0031983 | vesicle lumen(GO:0031983) |
2.4 | 4.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
2.3 | 4.7 | GO:0097413 | Lewy body(GO:0097413) |
2.3 | 118.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
2.3 | 11.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.3 | 18.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
2.3 | 25.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.3 | 16.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
2.2 | 6.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
2.2 | 2.2 | GO:0034464 | BBSome(GO:0034464) |
2.2 | 6.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.2 | 47.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
2.1 | 44.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
2.1 | 23.2 | GO:0035102 | PRC1 complex(GO:0035102) |
2.1 | 16.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
2.1 | 6.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
2.0 | 12.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.0 | 16.3 | GO:0042587 | glycogen granule(GO:0042587) |
2.0 | 6.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
2.0 | 48.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
2.0 | 12.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
2.0 | 8.0 | GO:0001650 | fibrillar center(GO:0001650) |
2.0 | 6.0 | GO:0005955 | calcineurin complex(GO:0005955) |
2.0 | 3.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.9 | 11.6 | GO:0016589 | NURF complex(GO:0016589) |
1.9 | 1.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.9 | 7.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.9 | 5.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.9 | 19.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.9 | 13.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.9 | 7.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.9 | 3.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.9 | 1.9 | GO:0097386 | glial cell projection(GO:0097386) |
1.8 | 9.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.8 | 5.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.8 | 7.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.8 | 19.6 | GO:0031528 | microvillus membrane(GO:0031528) |
1.8 | 17.6 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.8 | 7.0 | GO:0000938 | GARP complex(GO:0000938) |
1.7 | 82.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
1.7 | 5.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.7 | 88.4 | GO:0005811 | lipid particle(GO:0005811) |
1.7 | 6.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.7 | 10.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.7 | 5.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.7 | 1.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.7 | 5.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.7 | 5.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.7 | 1.7 | GO:0061574 | ASAP complex(GO:0061574) |
1.7 | 5.0 | GO:0000346 | transcription export complex(GO:0000346) |
1.7 | 146.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.6 | 8.2 | GO:0005638 | lamin filament(GO:0005638) |
1.6 | 3.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.6 | 43.8 | GO:0008305 | integrin complex(GO:0008305) |
1.6 | 72.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
1.6 | 6.4 | GO:0098536 | deuterosome(GO:0098536) |
1.6 | 11.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.6 | 6.4 | GO:0035363 | histone locus body(GO:0035363) |
1.6 | 4.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.6 | 12.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.6 | 9.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.6 | 4.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
1.6 | 91.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.6 | 3.2 | GO:0001739 | sex chromatin(GO:0001739) |
1.6 | 7.8 | GO:0097255 | R2TP complex(GO:0097255) |
1.6 | 3.1 | GO:0071203 | WASH complex(GO:0071203) |
1.5 | 7.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.5 | 4.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.5 | 15.0 | GO:0032982 | myosin filament(GO:0032982) |
1.5 | 5.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.5 | 1.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.5 | 151.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
1.5 | 5.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.5 | 4.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.5 | 10.2 | GO:0000801 | central element(GO:0000801) |
1.4 | 4.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.4 | 11.5 | GO:0042581 | specific granule(GO:0042581) |
1.4 | 10.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.4 | 4.3 | GO:0043218 | compact myelin(GO:0043218) |
1.4 | 9.8 | GO:0042382 | paraspeckles(GO:0042382) |
1.4 | 5.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.4 | 77.6 | GO:0016605 | PML body(GO:0016605) |
1.4 | 9.6 | GO:0005916 | fascia adherens(GO:0005916) |
1.4 | 4.1 | GO:1990635 | proximal dendrite(GO:1990635) |
1.4 | 17.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
1.4 | 130.5 | GO:0005903 | brush border(GO:0005903) |
1.4 | 8.2 | GO:0031512 | motile primary cilium(GO:0031512) |
1.3 | 1.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.3 | 2.7 | GO:0014704 | intercalated disc(GO:0014704) |
1.3 | 9.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.3 | 5.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.3 | 6.6 | GO:0042629 | mast cell granule(GO:0042629) |
1.3 | 109.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.3 | 14.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.3 | 7.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.3 | 2.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.3 | 6.4 | GO:0002177 | manchette(GO:0002177) |
1.3 | 3.9 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
1.3 | 2.6 | GO:0031090 | organelle membrane(GO:0031090) |
1.3 | 2.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.3 | 3.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.3 | 53.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.2 | 10.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.2 | 3.7 | GO:0034706 | sodium channel complex(GO:0034706) |
1.2 | 17.3 | GO:0000786 | nucleosome(GO:0000786) |
1.2 | 26.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.2 | 10.9 | GO:0045171 | intercellular bridge(GO:0045171) |
1.2 | 2.4 | GO:0051286 | cell tip(GO:0051286) |
1.2 | 47.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.2 | 9.6 | GO:0070652 | HAUS complex(GO:0070652) |
1.2 | 14.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.2 | 11.9 | GO:0043196 | varicosity(GO:0043196) |
1.2 | 27.2 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
1.2 | 15.3 | GO:0036038 | MKS complex(GO:0036038) |
1.2 | 2.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.2 | 11.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.2 | 1.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.2 | 7.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.2 | 10.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.2 | 4.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.2 | 12.7 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
1.2 | 9.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
1.1 | 3.4 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.1 | 12.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.1 | 22.7 | GO:0090544 | BAF-type complex(GO:0090544) |
1.1 | 12.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.1 | 2.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
1.1 | 5.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
1.1 | 3.3 | GO:0000322 | storage vacuole(GO:0000322) |
1.1 | 5.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.1 | 4.3 | GO:0005869 | dynactin complex(GO:0005869) |
1.1 | 3.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.1 | 3.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.1 | 11.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.1 | 13.8 | GO:0005844 | polysome(GO:0005844) |
1.1 | 1.1 | GO:0030056 | hemidesmosome(GO:0030056) |
1.1 | 22.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.1 | 5.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.1 | 54.9 | GO:0016363 | nuclear matrix(GO:0016363) |
1.1 | 4.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.1 | 5.3 | GO:0005796 | Golgi lumen(GO:0005796) |
1.0 | 27.3 | GO:0016592 | mediator complex(GO:0016592) |
1.0 | 2.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.0 | 4.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.0 | 2.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.0 | 4.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.0 | 7.2 | GO:0031143 | pseudopodium(GO:0031143) |
1.0 | 17.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.0 | 9.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.0 | 25.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.0 | 27.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.0 | 9.2 | GO:0097225 | sperm midpiece(GO:0097225) |
1.0 | 35.6 | GO:0005776 | autophagosome(GO:0005776) |
1.0 | 5.1 | GO:0005915 | zonula adherens(GO:0005915) |
1.0 | 2.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
1.0 | 11.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.0 | 24.1 | GO:0016459 | myosin complex(GO:0016459) |
1.0 | 3.0 | GO:0005712 | chiasma(GO:0005712) |
1.0 | 8.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
1.0 | 156.1 | GO:0000139 | Golgi membrane(GO:0000139) |
1.0 | 4.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.0 | 11.7 | GO:0031941 | filamentous actin(GO:0031941) |
1.0 | 2.9 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.0 | 5.8 | GO:0001520 | outer dense fiber(GO:0001520) |
1.0 | 4.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.9 | 6.6 | GO:0030904 | retromer complex(GO:0030904) |
0.9 | 2.8 | GO:0016342 | catenin complex(GO:0016342) |
0.9 | 11.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.9 | 2.8 | GO:0005902 | microvillus(GO:0005902) |
0.9 | 10.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.9 | 74.0 | GO:0030496 | midbody(GO:0030496) |
0.9 | 3.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.9 | 2.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.9 | 2.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.9 | 20.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.9 | 10.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.9 | 6.4 | GO:0030120 | vesicle coat(GO:0030120) |
0.9 | 2.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.9 | 3.6 | GO:0072487 | MSL complex(GO:0072487) |
0.9 | 3.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.9 | 6.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.9 | 1.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.9 | 0.9 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.9 | 2.7 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.9 | 4.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.9 | 7.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.9 | 2.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 7.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.9 | 8.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.9 | 3.6 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.9 | 2.6 | GO:0030689 | Noc complex(GO:0030689) |
0.9 | 22.8 | GO:0005901 | caveola(GO:0005901) |
0.9 | 5.3 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.9 | 30.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.9 | 3.5 | GO:0001652 | granular component(GO:0001652) |
0.9 | 8.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.9 | 0.9 | GO:0042585 | germinal vesicle(GO:0042585) |
0.9 | 2.6 | GO:0043293 | apoptosome(GO:0043293) |
0.9 | 10.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.9 | 7.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.8 | 1.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.8 | 10.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.8 | 4.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.8 | 6.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.8 | 4.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.8 | 1.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.8 | 174.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.8 | 65.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.8 | 6.5 | GO:0097546 | ciliary base(GO:0097546) |
0.8 | 8.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.8 | 2.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.8 | 11.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.8 | 8.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.8 | 2.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.8 | 3.2 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.8 | 6.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.8 | 4.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.8 | 4.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.8 | 3.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.8 | 4.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.8 | 8.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.8 | 1.6 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.8 | 2.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.8 | 14.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.8 | 3.9 | GO:0042641 | actomyosin(GO:0042641) |
0.8 | 164.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.8 | 7.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 9.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.8 | 1.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.8 | 3.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.8 | 3.0 | GO:0034709 | methylosome(GO:0034709) |
0.8 | 16.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.8 | 6.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.8 | 0.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.8 | 13.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.8 | 2.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.8 | 3.0 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.7 | 1.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 10.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.7 | 9.7 | GO:0071010 | prespliceosome(GO:0071010) |
0.7 | 5.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.7 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.7 | 96.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.7 | 5.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.7 | 5.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.7 | 1253.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.7 | 2.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.7 | 11.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.7 | 2.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.7 | 160.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.7 | 3.6 | GO:0002102 | podosome(GO:0002102) |
0.7 | 745.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.7 | 1.4 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.7 | 2.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.7 | 0.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.7 | 2.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.7 | 0.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.7 | 2.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.7 | 3.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.7 | 7.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.7 | 0.7 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.7 | 4.1 | GO:0012505 | endomembrane system(GO:0012505) |
0.7 | 1.4 | GO:1990923 | PET complex(GO:1990923) |
0.7 | 1.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.7 | 43.1 | GO:0000785 | chromatin(GO:0000785) |
0.7 | 2.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.7 | 4.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 1.3 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 2.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.6 | 0.6 | GO:0045178 | basal part of cell(GO:0045178) |
0.6 | 0.6 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 1.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.6 | 1.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.6 | 1.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.6 | 349.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.6 | 1.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.6 | 5.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.6 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.6 | 0.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.6 | 8.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.6 | 9.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.6 | 34.1 | GO:0036064 | ciliary basal body(GO:0036064) |
0.6 | 92.4 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.6 | 41.1 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.6 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.6 | 1.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.6 | 1.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.6 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
0.6 | 39.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.6 | 0.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 0.6 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.6 | 1.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.6 | 3.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.6 | 1.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.6 | 0.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.6 | 0.6 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.5 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.5 | 1.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.5 | 4.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.5 | 1.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.5 | 1.1 | GO:0044309 | neuron spine(GO:0044309) |
0.5 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.5 | 2.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.5 | 3.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.5 | 5.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.5 | 13.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.5 | 4.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.5 | 18.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.5 | 3.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.5 | 4.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 3.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 2.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.5 | 1.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.5 | 0.5 | GO:0036452 | ESCRT complex(GO:0036452) |
0.5 | 1.0 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.5 | 1.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.5 | 5.6 | GO:0005884 | actin filament(GO:0005884) |
0.5 | 1.4 | GO:0042599 | lamellar body(GO:0042599) |
0.4 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.4 | 2.2 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 4.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.4 | 0.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 186.3 | GO:0005829 | cytosol(GO:0005829) |
0.4 | 17.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 276.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.4 | 83.7 | GO:0005730 | nucleolus(GO:0005730) |
0.4 | 23.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.4 | 5.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 0.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 38.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.4 | 14.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.4 | 5.5 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 34.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.4 | 15.9 | GO:0045177 | apical part of cell(GO:0045177) |
0.4 | 17.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.4 | 0.4 | GO:1990696 | USH2 complex(GO:1990696) |
0.4 | 2.6 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 5.8 | GO:0043234 | protein complex(GO:0043234) |
0.4 | 201.7 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 1.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 0.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 46.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 0.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.3 | 5.0 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 0.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 1.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 0.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.3 | 10.9 | GO:0005769 | early endosome(GO:0005769) |
0.3 | 0.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 1.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 4.3 | GO:0010008 | endosome membrane(GO:0010008) |
0.3 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.3 | 4.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 113.0 | GO:0005576 | extracellular region(GO:0005576) |
0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 4.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 17.8 | GO:1990234 | transferase complex(GO:1990234) |
0.2 | 0.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 0.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 1.0 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 1.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 0.2 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 0.3 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 452.0 | GO:0005622 | intracellular(GO:0005622) |
0.1 | 324.2 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.9 | 44.8 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
12.1 | 36.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
9.8 | 29.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
9.3 | 28.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
9.3 | 27.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
9.3 | 27.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
8.4 | 33.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
8.0 | 23.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
7.9 | 23.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
7.5 | 37.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
7.4 | 22.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
7.3 | 21.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
7.2 | 29.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
7.2 | 21.7 | GO:0030620 | U2 snRNA binding(GO:0030620) |
6.8 | 20.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
6.3 | 31.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
6.3 | 31.5 | GO:0005499 | vitamin D binding(GO:0005499) |
6.3 | 18.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
6.1 | 36.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
6.0 | 18.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
5.7 | 40.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
5.6 | 16.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
5.5 | 5.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
5.5 | 27.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
5.5 | 21.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
5.4 | 27.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
5.3 | 37.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
5.3 | 15.9 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
5.2 | 5.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
5.1 | 10.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
5.1 | 15.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
5.0 | 15.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
4.9 | 34.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
4.8 | 38.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
4.7 | 14.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
4.7 | 32.7 | GO:0018651 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
4.7 | 32.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
4.7 | 18.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
4.4 | 13.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
4.4 | 17.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
4.3 | 13.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
4.3 | 25.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
4.3 | 25.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
4.3 | 17.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
4.2 | 67.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
4.2 | 33.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
4.1 | 48.7 | GO:0005542 | folic acid binding(GO:0005542) |
4.1 | 12.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
4.0 | 12.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
4.0 | 15.8 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
3.9 | 54.9 | GO:0010181 | FMN binding(GO:0010181) |
3.9 | 11.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
3.9 | 15.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
3.8 | 22.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
3.8 | 11.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
3.8 | 7.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
3.8 | 30.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
3.8 | 15.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
3.8 | 15.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
3.7 | 25.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
3.7 | 18.4 | GO:0070061 | fructose binding(GO:0070061) |
3.6 | 25.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
3.6 | 28.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
3.6 | 7.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
3.6 | 10.7 | GO:0070538 | oleic acid binding(GO:0070538) |
3.5 | 3.5 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
3.5 | 24.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
3.5 | 17.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
3.5 | 10.4 | GO:0008142 | oxysterol binding(GO:0008142) |
3.3 | 3.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
3.3 | 6.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
3.3 | 13.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
3.3 | 9.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
3.2 | 3.2 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
3.2 | 9.6 | GO:0004096 | catalase activity(GO:0004096) |
3.2 | 9.5 | GO:0019961 | interferon binding(GO:0019961) |
3.2 | 3.2 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
3.1 | 9.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
3.1 | 9.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
3.1 | 6.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.1 | 12.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
3.1 | 18.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
3.0 | 15.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
3.0 | 9.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
3.0 | 11.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
3.0 | 5.9 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
3.0 | 8.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
3.0 | 3.0 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
2.9 | 8.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.9 | 20.5 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
2.9 | 14.5 | GO:0016803 | ether hydrolase activity(GO:0016803) |
2.9 | 46.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
2.9 | 8.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
2.9 | 8.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
2.8 | 8.5 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
2.8 | 17.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
2.8 | 25.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
2.8 | 5.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
2.8 | 14.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
2.8 | 33.2 | GO:0017166 | vinculin binding(GO:0017166) |
2.8 | 24.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
2.8 | 5.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.8 | 8.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
2.8 | 2.8 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
2.7 | 11.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.7 | 8.2 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.7 | 24.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.7 | 43.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
2.7 | 75.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
2.7 | 16.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
2.7 | 13.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
2.7 | 5.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
2.7 | 18.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
2.7 | 13.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
2.6 | 7.9 | GO:0050692 | DBD domain binding(GO:0050692) |
2.6 | 10.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.6 | 10.4 | GO:0009374 | biotin binding(GO:0009374) |
2.6 | 7.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.5 | 2.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
2.5 | 5.0 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
2.5 | 27.7 | GO:0005536 | glucose binding(GO:0005536) |
2.5 | 7.6 | GO:0004064 | arylesterase activity(GO:0004064) |
2.5 | 12.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
2.5 | 12.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.4 | 22.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
2.4 | 12.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
2.4 | 26.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
2.4 | 14.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.4 | 14.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
2.4 | 4.8 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
2.4 | 43.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
2.4 | 126.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
2.4 | 7.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.4 | 31.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
2.4 | 4.8 | GO:0019842 | vitamin binding(GO:0019842) |
2.3 | 11.7 | GO:0008430 | selenium binding(GO:0008430) |
2.3 | 9.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
2.3 | 2.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
2.3 | 13.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
2.3 | 16.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
2.3 | 6.9 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
2.3 | 9.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.3 | 13.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
2.3 | 18.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
2.3 | 25.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
2.3 | 2.3 | GO:0051425 | PTB domain binding(GO:0051425) |
2.3 | 11.4 | GO:0017040 | ceramidase activity(GO:0017040) |
2.3 | 31.8 | GO:0005123 | death receptor binding(GO:0005123) |
2.3 | 2.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
2.3 | 11.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.3 | 6.8 | GO:0055100 | adiponectin binding(GO:0055100) |
2.3 | 9.0 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
2.3 | 9.0 | GO:0043515 | kinetochore binding(GO:0043515) |
2.2 | 2.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
2.2 | 2.2 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
2.2 | 4.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
2.2 | 4.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.2 | 11.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
2.2 | 10.9 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
2.2 | 8.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
2.2 | 21.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
2.1 | 8.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
2.1 | 2.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
2.1 | 6.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
2.1 | 6.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
2.1 | 4.3 | GO:0034618 | arginine binding(GO:0034618) |
2.1 | 8.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
2.1 | 6.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.1 | 8.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
2.1 | 18.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.1 | 8.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.1 | 2.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.0 | 22.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
2.0 | 6.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.0 | 36.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
2.0 | 6.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
2.0 | 2.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
2.0 | 22.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
2.0 | 2.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
2.0 | 8.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
2.0 | 27.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
2.0 | 11.9 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
2.0 | 15.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.0 | 5.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.0 | 9.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
2.0 | 9.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.0 | 5.9 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
2.0 | 2.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.9 | 13.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.9 | 15.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.9 | 5.8 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.9 | 7.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.9 | 7.7 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
1.9 | 13.4 | GO:0000150 | recombinase activity(GO:0000150) |
1.9 | 7.7 | GO:0042731 | PH domain binding(GO:0042731) |
1.9 | 5.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.9 | 15.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.9 | 1.9 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
1.9 | 11.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.9 | 1.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.9 | 13.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.9 | 11.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.9 | 31.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
1.9 | 1.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.9 | 18.5 | GO:0044548 | S100 protein binding(GO:0044548) |
1.9 | 7.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.8 | 9.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.8 | 5.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.8 | 25.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
1.8 | 7.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.8 | 14.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.8 | 21.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.8 | 5.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.8 | 18.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
1.8 | 3.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.8 | 32.5 | GO:0008483 | transaminase activity(GO:0008483) |
1.8 | 50.0 | GO:0015485 | cholesterol binding(GO:0015485) |
1.8 | 16.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.8 | 1.8 | GO:0038132 | neuregulin binding(GO:0038132) |
1.8 | 7.1 | GO:0071253 | connexin binding(GO:0071253) |
1.8 | 5.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.8 | 5.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.8 | 70.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.7 | 1.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.7 | 17.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
1.7 | 78.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
1.7 | 12.1 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.7 | 10.3 | GO:0015288 | porin activity(GO:0015288) |
1.7 | 3.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.7 | 8.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.7 | 37.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.7 | 15.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.7 | 6.8 | GO:0070728 | leucine binding(GO:0070728) |
1.7 | 28.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.7 | 3.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.7 | 6.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.7 | 15.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.7 | 5.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.7 | 6.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
1.7 | 23.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.7 | 16.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
1.7 | 10.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.7 | 1.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.7 | 5.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.7 | 3.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.6 | 16.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.6 | 1.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.6 | 6.6 | GO:0035671 | enone reductase activity(GO:0035671) |
1.6 | 6.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.6 | 4.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.6 | 35.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
1.6 | 74.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
1.6 | 4.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.6 | 14.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.6 | 1.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.6 | 4.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.6 | 3.2 | GO:0070052 | collagen V binding(GO:0070052) |
1.6 | 36.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.6 | 14.4 | GO:0001846 | opsonin binding(GO:0001846) |
1.6 | 9.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
1.6 | 6.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.6 | 9.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.6 | 4.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.6 | 6.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.6 | 18.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.5 | 10.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.5 | 4.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.5 | 50.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.5 | 26.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.5 | 9.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.5 | 6.1 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
1.5 | 4.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
1.5 | 6.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.5 | 3.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.5 | 10.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.5 | 4.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
1.5 | 26.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.5 | 4.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.5 | 41.2 | GO:0043531 | ADP binding(GO:0043531) |
1.5 | 2.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
1.5 | 1.5 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
1.5 | 36.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.5 | 4.4 | GO:0004103 | choline kinase activity(GO:0004103) |
1.5 | 4.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.5 | 5.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
1.5 | 4.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
1.5 | 17.5 | GO:0043274 | phospholipase binding(GO:0043274) |
1.5 | 4.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.5 | 27.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.4 | 11.5 | GO:0019825 | oxygen binding(GO:0019825) |
1.4 | 1.4 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.4 | 2.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.4 | 12.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.4 | 1.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.4 | 4.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.4 | 17.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.4 | 14.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.4 | 26.8 | GO:0017069 | snRNA binding(GO:0017069) |
1.4 | 1.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.4 | 1.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.4 | 4.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.4 | 9.8 | GO:0001848 | complement binding(GO:0001848) |
1.4 | 60.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
1.4 | 9.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
1.4 | 2.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.4 | 16.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
1.4 | 1.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.4 | 54.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
1.4 | 2.8 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
1.4 | 2.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.4 | 31.2 | GO:0050661 | NADP binding(GO:0050661) |
1.4 | 10.8 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
1.3 | 4.0 | GO:0043199 | sulfate binding(GO:0043199) |
1.3 | 4.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.3 | 4.0 | GO:0015232 | heme transporter activity(GO:0015232) |
1.3 | 4.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.3 | 5.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.3 | 137.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.3 | 5.3 | GO:0031014 | troponin T binding(GO:0031014) |
1.3 | 2.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.3 | 3.9 | GO:0048030 | disaccharide binding(GO:0048030) |
1.3 | 2.6 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
1.3 | 18.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
1.3 | 2.6 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.3 | 2.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.3 | 7.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.3 | 5.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.3 | 25.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.3 | 25.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.3 | 22.9 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.3 | 3.8 | GO:0000339 | RNA cap binding(GO:0000339) |
1.3 | 2.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.3 | 2.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.3 | 3.8 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.3 | 6.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.3 | 2.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.3 | 12.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.2 | 5.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.2 | 1.2 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.2 | 11.1 | GO:0005521 | lamin binding(GO:0005521) |
1.2 | 8.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.2 | 4.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.2 | 4.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.2 | 3.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.2 | 9.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.2 | 2.4 | GO:0015928 | fucosidase activity(GO:0015928) |
1.2 | 3.6 | GO:0031419 | cobalamin binding(GO:0031419) |
1.2 | 2.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.2 | 5.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.2 | 4.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.2 | 2.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
1.2 | 13.0 | GO:0019841 | retinol binding(GO:0019841) |
1.2 | 5.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.2 | 28.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
1.2 | 5.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.2 | 10.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.2 | 2.4 | GO:0035198 | miRNA binding(GO:0035198) |
1.2 | 35.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.2 | 5.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.2 | 45.6 | GO:0005507 | copper ion binding(GO:0005507) |
1.2 | 10.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.2 | 3.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
1.2 | 7.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.2 | 3.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.2 | 3.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.2 | 9.3 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
1.2 | 3.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.2 | 3.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
1.2 | 3.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.2 | 197.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.2 | 11.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.1 | 3.4 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.1 | 5.7 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
1.1 | 5.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.1 | 33.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.1 | 1.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
1.1 | 6.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.1 | 2.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
1.1 | 11.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.1 | 5.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.1 | 13.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
1.1 | 10.1 | GO:0036218 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
1.1 | 5.6 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.1 | 1.1 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
1.1 | 2.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.1 | 23.5 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
1.1 | 3.3 | GO:0031432 | titin binding(GO:0031432) |
1.1 | 6.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.1 | 13.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
1.1 | 10.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.1 | 4.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.1 | 16.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.1 | 3.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
1.1 | 9.9 | GO:0070636 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
1.1 | 7.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.1 | 6.6 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.1 | 5.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.1 | 4.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.1 | 2.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.1 | 4.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.1 | 6.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
1.1 | 4.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
1.1 | 7.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.1 | 3.3 | GO:1990188 | euchromatin binding(GO:1990188) |
1.1 | 111.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.1 | 5.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.1 | 32.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
1.1 | 8.5 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
1.1 | 13.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.1 | 7.4 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.1 | 3.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.1 | 4.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.0 | 42.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
1.0 | 4.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.0 | 6.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.0 | 9.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.0 | 4.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.0 | 7.2 | GO:0003796 | lysozyme activity(GO:0003796) |
1.0 | 1.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
1.0 | 3.1 | GO:0046790 | virion binding(GO:0046790) |
1.0 | 1.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.0 | 4.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.0 | 4.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.0 | 2.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.0 | 1.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.0 | 4.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.0 | 8.1 | GO:0034793 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
1.0 | 12.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.0 | 2.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.0 | 2.0 | GO:0043495 | protein anchor(GO:0043495) |
1.0 | 4.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.0 | 3.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.0 | 10.0 | GO:0008198 | ferrous iron binding(GO:0008198) |
1.0 | 1.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.0 | 2.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.0 | 3.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
1.0 | 3.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.0 | 11.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.0 | 1.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
1.0 | 32.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.0 | 1.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.0 | 2.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.0 | 2.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.0 | 2.9 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.0 | 1.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.0 | 8.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.0 | 1.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.0 | 8.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
1.0 | 9.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
1.0 | 3.8 | GO:0016936 | galactoside binding(GO:0016936) |
1.0 | 1.0 | GO:0004386 | helicase activity(GO:0004386) |
1.0 | 66.1 | GO:0035326 | enhancer binding(GO:0035326) |
1.0 | 5.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.0 | 16.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.9 | 7.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.9 | 2.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.9 | 11.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.9 | 2.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.9 | 0.9 | GO:0043426 | MRF binding(GO:0043426) |
0.9 | 1.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.9 | 1.9 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.9 | 2.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.9 | 0.9 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.9 | 2.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.9 | 2.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.9 | 0.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.9 | 4.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.9 | 5.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.9 | 5.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.9 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 21.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.9 | 28.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.9 | 40.8 | GO:0000149 | SNARE binding(GO:0000149) |
0.9 | 8.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.9 | 15.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.9 | 2.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.9 | 7.2 | GO:0031005 | filamin binding(GO:0031005) |
0.9 | 30.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.9 | 0.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.9 | 76.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.9 | 2.7 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.9 | 3.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.9 | 8.0 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.9 | 3.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.9 | 6.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.9 | 8.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.9 | 15.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.9 | 4.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.9 | 7.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.9 | 20.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.9 | 2.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.9 | 6.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.9 | 4.3 | GO:0016208 | AMP binding(GO:0016208) |
0.9 | 1.7 | GO:0033265 | choline binding(GO:0033265) |
0.8 | 0.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.8 | 6.8 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.8 | 4.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.8 | 5.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.8 | 1.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.8 | 14.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.8 | 3.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.8 | 15.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.8 | 2.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.8 | 1.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.8 | 2.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.8 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.8 | 3.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.8 | 0.8 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.8 | 41.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.8 | 12.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.8 | 0.8 | GO:0031404 | chloride ion binding(GO:0031404) |
0.8 | 4.0 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.8 | 1.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.8 | 4.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.8 | 3.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.8 | 2.4 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.8 | 4.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.8 | 138.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.8 | 1.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.8 | 3.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.8 | 12.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.8 | 0.8 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.8 | 1.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.8 | 2.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.8 | 1.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.8 | 15.9 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.8 | 1.6 | GO:0015605 | nucleotide transmembrane transporter activity(GO:0015215) organophosphate ester transmembrane transporter activity(GO:0015605) |
0.8 | 6.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.8 | 20.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.8 | 1.6 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.8 | 0.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.8 | 2.4 | GO:0035473 | lipase binding(GO:0035473) |
0.8 | 9.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.8 | 1.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.8 | 7.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.8 | 19.4 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.8 | 43.9 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.8 | 9.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.8 | 3.8 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.8 | 2.3 | GO:0002046 | opsin binding(GO:0002046) |
0.8 | 2.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.8 | 1.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.8 | 3.8 | GO:0070888 | E-box binding(GO:0070888) |
0.8 | 52.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.8 | 2.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.8 | 5.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.8 | 4.5 | GO:0018448 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.8 | 0.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.7 | 1.5 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.7 | 1.5 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.7 | 4.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.7 | 5.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.7 | 0.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.7 | 2.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 2.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.7 | 2.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.7 | 13.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.7 | 0.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.7 | 8.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.7 | 0.7 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.7 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.7 | 3.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.7 | 1.4 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.7 | 1.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.7 | 7.8 | GO:0009975 | cyclase activity(GO:0009975) |
0.7 | 22.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.7 | 43.8 | GO:0005178 | integrin binding(GO:0005178) |
0.7 | 1.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.7 | 7.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.7 | 2.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 1.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.7 | 2.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.7 | 11.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.7 | 33.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.7 | 1.4 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.7 | 2.0 | GO:0019002 | GMP binding(GO:0019002) |
0.7 | 2.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.7 | 0.7 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.7 | 1.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.7 | 8.1 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.7 | 2.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.7 | 11.4 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.7 | 8.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.7 | 1.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.7 | 7.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.7 | 5.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.7 | 1.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.7 | 10.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.7 | 8.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.6 | 2.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 5.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.6 | 4.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.6 | 2.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 1.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.6 | 3.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 5.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.6 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.6 | 1.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 6.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.6 | 2.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.6 | 1.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 4.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.6 | 1.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.6 | 0.6 | GO:0070697 | activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
0.6 | 13.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.6 | 6.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.6 | 1.2 | GO:0038100 | nodal binding(GO:0038100) |
0.6 | 5.4 | GO:0032451 | demethylase activity(GO:0032451) |
0.6 | 2.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 0.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.6 | 3.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.6 | 1.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.6 | 1.8 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.6 | 47.3 | GO:0042393 | histone binding(GO:0042393) |
0.6 | 6.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.6 | 11.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.6 | 2.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.6 | 1.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.6 | 1.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 14.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.6 | 51.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.6 | 6.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 1.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.6 | 2.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 1.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 8.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.6 | 0.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.6 | 2.3 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.6 | 1.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.6 | 71.5 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.6 | 1.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 18.4 | GO:0002039 | p53 binding(GO:0002039) |
0.6 | 3.9 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.6 | 69.6 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.6 | 1.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 2.2 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.6 | 1.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 17.5 | GO:0005518 | collagen binding(GO:0005518) |
0.5 | 1.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.5 | 70.1 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.5 | 45.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.5 | 1.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 45.0 | GO:0051020 | GTPase binding(GO:0051020) |
0.5 | 26.2 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.5 | 0.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.5 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 3.2 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.5 | 1.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.5 | 1.1 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.5 | 16.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.5 | 2.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.5 | 9.4 | GO:0045502 | dynein binding(GO:0045502) |
0.5 | 32.8 | GO:0001047 | core promoter binding(GO:0001047) |
0.5 | 2.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.5 | 5.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 4.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.5 | 2.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 1.0 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.5 | 1.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.5 | 1.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.5 | 2.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 28.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.5 | 1.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.5 | 1.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.5 | 1.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.5 | 85.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.5 | 1.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 2.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.5 | 2.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.5 | 8.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 1.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 1.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.5 | 3.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 4.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.5 | 0.5 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.5 | 2.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.5 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 0.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 1.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.5 | 1.4 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 18.9 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.5 | 6.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.5 | 1.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.5 | 0.5 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.5 | 0.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.4 | 4.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 3.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.4 | 46.1 | GO:0005179 | hormone activity(GO:0005179) |
0.4 | 17.0 | GO:0019003 | GDP binding(GO:0019003) |
0.4 | 2.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 0.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.4 | 6.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.4 | 1.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 1.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.4 | 11.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.4 | 2.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 2.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 3.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.4 | 63.3 | GO:0003682 | chromatin binding(GO:0003682) |
0.4 | 0.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.4 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 0.4 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.4 | 2.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 1.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.4 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 3.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.4 | 1.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 4.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.4 | 40.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.4 | 1.6 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.4 | 2.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 4.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 1.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.4 | 1.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.4 | 2.8 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 2.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 1.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.4 | 7.6 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.4 | 1.6 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.4 | 2.0 | GO:0015266 | protein channel activity(GO:0015266) |
0.4 | 1.9 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.4 | 5.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.4 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 0.8 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.4 | 1.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.4 | 1.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 6.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.4 | 0.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 1.1 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.4 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 1.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 16.5 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.4 | 5.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 2.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.4 | 0.7 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.3 | 3.5 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.3 | 13.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.3 | 3.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 4.8 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 12.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.3 | 3.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 1.0 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.3 | 3.0 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.3 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 4.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 1.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.3 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.3 | 6.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 6.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 3.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 1.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 1.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 4.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.3 | 1.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 0.6 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.3 | 1.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 0.3 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.3 | 5.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 1.7 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.3 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
0.3 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.3 | 2.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.3 | 2.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 1.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 0.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 1.9 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 11.6 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.3 | 1.9 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.3 | 0.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 2.4 | GO:0005550 | pheromone binding(GO:0005550) |
0.3 | 0.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.3 | 1.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 1.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 4.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.3 | 47.4 | GO:0005525 | GTP binding(GO:0005525) |
0.3 | 1.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 5.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 1.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 0.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.3 | 0.8 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 229.3 | GO:0003677 | DNA binding(GO:0003677) |
0.3 | 1.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.3 | 1.0 | GO:0070990 | snRNP binding(GO:0070990) |
0.3 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 4.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 3.6 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 3.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 4.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.2 | 2.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 3.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 1.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 1.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 1.5 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.2 | 4.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 2.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 39.8 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 12.6 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 1.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 2.1 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.2 | 1.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 1.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 1.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 1.8 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.2 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 0.4 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 0.2 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 46.8 | GO:0008270 | zinc ion binding(GO:0008270) |
0.2 | 10.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.2 | 0.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 1.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 32.7 | GO:0005198 | structural molecule activity(GO:0005198) |
0.2 | 4.9 | GO:0004518 | nuclease activity(GO:0004518) |
0.2 | 0.2 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.2 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.2 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.3 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.2 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 1.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 17.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 0.3 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.1 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 9.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.1 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 4.4 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.1 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.1 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 3.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 2.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.5 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.5 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 3.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 39.2 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 7.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.3 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.1 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 44.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.6 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.0 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 1.0 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 1.5 | GO:0016791 | phosphatase activity(GO:0016791) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 100.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
3.9 | 100.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
3.8 | 11.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
3.4 | 85.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
2.9 | 5.9 | PID IFNG PATHWAY | IFN-gamma pathway |
2.8 | 69.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
2.6 | 112.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.4 | 9.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
2.4 | 31.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
2.4 | 106.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.4 | 16.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.4 | 30.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
2.3 | 32.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
2.3 | 82.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
2.2 | 12.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
2.1 | 40.1 | PID AURORA A PATHWAY | Aurora A signaling |
2.1 | 20.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.0 | 13.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
2.0 | 35.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.9 | 44.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.9 | 71.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.9 | 28.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.9 | 22.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.8 | 7.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.8 | 17.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.7 | 44.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.7 | 6.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.6 | 27.7 | ST GAQ PATHWAY | G alpha q Pathway |
1.6 | 13.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.6 | 42.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.6 | 22.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.6 | 37.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.5 | 38.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.5 | 35.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.5 | 35.1 | PID RHOA PATHWAY | RhoA signaling pathway |
1.5 | 24.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.5 | 5.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.5 | 4.4 | PID MYC PATHWAY | C-MYC pathway |
1.4 | 7.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.4 | 29.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.4 | 11.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.4 | 8.2 | PID IGF1 PATHWAY | IGF1 pathway |
1.4 | 1.4 | ST STAT3 PATHWAY | STAT3 Pathway |
1.4 | 66.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.4 | 57.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.3 | 19.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.3 | 6.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.3 | 47.2 | PID P53 REGULATION PATHWAY | p53 pathway |
1.3 | 6.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.3 | 15.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.2 | 8.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.2 | 20.9 | PID RAS PATHWAY | Regulation of Ras family activation |
1.2 | 17.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
1.2 | 9.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.2 | 19.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.1 | 29.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.1 | 33.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
1.1 | 221.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.1 | 13.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.1 | 16.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.1 | 24.9 | PID ARF6 PATHWAY | Arf6 signaling events |
1.1 | 2.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.1 | 2.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.1 | 9.6 | PID EPO PATHWAY | EPO signaling pathway |
1.1 | 43.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.0 | 3.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.0 | 10.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.0 | 8.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.0 | 15.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.0 | 11.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.0 | 18.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.0 | 22.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.0 | 12.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.0 | 5.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.0 | 9.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.0 | 28.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
1.0 | 2.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.0 | 3.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.0 | 17.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.9 | 14.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.9 | 11.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.9 | 10.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.9 | 1.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.9 | 2.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.9 | 8.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.9 | 2.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.9 | 6.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.9 | 1.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.9 | 7.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.8 | 2.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.8 | 2.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.8 | 3.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.8 | 19.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.8 | 0.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.8 | 4.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.8 | 10.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.8 | 12.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.8 | 10.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.8 | 18.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.8 | 33.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.8 | 19.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.8 | 10.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.8 | 18.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.8 | 19.0 | PID ATR PATHWAY | ATR signaling pathway |
0.8 | 43.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.7 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.7 | 19.1 | PID P73PATHWAY | p73 transcription factor network |
0.7 | 30.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.7 | 5.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.7 | 5.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.7 | 9.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.7 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.7 | 4.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.7 | 3.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.7 | 2.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.7 | 5.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.7 | 4.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.7 | 22.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.7 | 19.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.7 | 9.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.6 | 2.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.6 | 5.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 6.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 1.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.6 | 7.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.6 | 11.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.5 | 1.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 9.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.5 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.5 | 8.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 2.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 2.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.5 | 7.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 62.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 2.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.5 | 11.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.5 | 1.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 11.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 5.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 2.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 1.9 | PID ATM PATHWAY | ATM pathway |
0.4 | 3.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 1.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 2.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 5.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 1.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 1.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 2.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 1.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 2.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 0.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 1.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 2.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 20.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 11.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 55.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
5.3 | 53.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
5.1 | 87.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
4.1 | 45.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
4.1 | 32.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
3.8 | 34.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
3.5 | 35.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
3.5 | 44.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
3.4 | 79.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
3.4 | 60.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
3.3 | 16.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
3.2 | 16.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
3.2 | 48.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
3.2 | 28.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
3.1 | 15.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
3.1 | 70.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
3.0 | 30.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
3.0 | 107.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
3.0 | 47.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.8 | 84.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.8 | 39.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.7 | 29.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
2.6 | 63.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.6 | 10.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
2.6 | 10.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
2.5 | 37.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
2.4 | 28.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.4 | 2.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
2.4 | 26.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
2.4 | 35.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
2.4 | 58.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
2.3 | 63.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
2.3 | 27.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.2 | 35.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
2.2 | 17.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
2.2 | 103.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
2.1 | 21.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
2.0 | 24.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
2.0 | 44.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.0 | 2.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.0 | 9.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
2.0 | 13.7 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
2.0 | 43.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.9 | 17.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.9 | 49.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.9 | 1.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.9 | 16.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.8 | 20.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.8 | 3.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.8 | 18.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.8 | 43.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.8 | 1.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
1.8 | 23.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.8 | 30.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.8 | 28.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.8 | 24.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.8 | 15.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.8 | 5.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.7 | 17.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.7 | 3.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.7 | 15.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.7 | 3.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
1.7 | 6.8 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
1.7 | 30.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.7 | 74.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.7 | 18.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.6 | 9.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.6 | 1.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.6 | 9.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.6 | 15.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.6 | 17.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.6 | 15.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.5 | 6.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
1.5 | 24.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.5 | 76.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.5 | 22.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.5 | 12.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.5 | 3.0 | REACTOME S PHASE | Genes involved in S Phase |
1.5 | 3.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
1.5 | 8.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.5 | 4.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.5 | 61.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.4 | 30.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.4 | 2.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.4 | 219.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.4 | 19.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.4 | 9.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.4 | 4.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
1.4 | 2.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.3 | 20.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.3 | 20.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.3 | 43.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
1.3 | 10.3 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
1.3 | 32.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.3 | 99.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.3 | 14.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
1.3 | 33.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.3 | 17.7 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
1.2 | 50.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.2 | 3.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.2 | 16.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.2 | 17.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.2 | 23.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.2 | 47.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.2 | 24.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.1 | 11.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.1 | 21.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.1 | 14.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.1 | 6.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
1.1 | 2.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
1.1 | 101.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.1 | 2.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.1 | 15.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.1 | 11.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.1 | 24.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.0 | 11.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.0 | 12.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.0 | 11.4 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
1.0 | 38.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
1.0 | 8.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.0 | 8.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.0 | 91.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
1.0 | 1.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.0 | 15.6 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
1.0 | 4.9 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
1.0 | 56.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.0 | 1.9 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
1.0 | 14.3 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
1.0 | 1.9 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.9 | 17.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.9 | 17.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.9 | 19.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.9 | 8.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.9 | 5.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.9 | 23.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.9 | 6.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.9 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.9 | 27.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.9 | 10.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.8 | 20.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.8 | 18.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.8 | 17.0 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.8 | 1.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.8 | 7.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.8 | 0.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.8 | 4.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.8 | 11.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.8 | 2.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.8 | 5.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.8 | 2.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.8 | 17.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.8 | 22.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.8 | 3.1 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.8 | 3.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.8 | 44.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.8 | 2.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.8 | 9.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.7 | 6.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.7 | 5.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 4.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.7 | 12.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.7 | 5.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.7 | 5.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.7 | 5.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.7 | 3.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.7 | 2.8 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.7 | 3.5 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.7 | 0.7 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.7 | 12.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.7 | 7.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.7 | 18.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.7 | 0.7 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.7 | 0.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.7 | 3.9 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.7 | 7.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.6 | 3.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.6 | 10.2 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.6 | 6.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.6 | 15.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.6 | 7.3 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.6 | 3.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.6 | 2.4 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.6 | 2.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.6 | 67.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.6 | 7.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.6 | 12.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.6 | 1.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.5 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.5 | 6.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.5 | 3.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 1.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 2.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 22.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.5 | 12.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.5 | 14.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 5.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 2.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 3.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 26.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 1.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 4.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 6.9 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
0.4 | 0.4 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.4 | 6.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 0.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.4 | 1.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 1.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.4 | 1.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.4 | 3.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 19.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.4 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 9.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 3.6 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.3 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 5.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 1.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 0.6 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.3 | 0.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 8.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 6.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 2.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 3.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 5.3 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.3 | 0.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 1.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 3.9 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 3.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 1.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 0.2 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
0.2 | 6.4 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.2 | 3.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 2.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 0.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 0.8 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.2 | 1.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 2.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 1.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 4.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 2.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 17.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 9.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.6 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 3.6 | REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | Genes involved in SLC-mediated transmembrane transport |
0.1 | 0.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.0 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
0.0 | 0.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |